candidate_genes,disease,celltype,y,user_question,full_query
"['ACTN4', 'MT-ND3', 'POU2F1', 'CA12', 'ADNP']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,MT-ND3,"Among the genes ACTN4, MT-ND3, POU2F1, CA12, and ADNP, which one exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it a promising target for follicular lymphoma?","Among the genes ACTN4, MT-ND3, POU2F1, CA12, and ADNP, which one exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells, making it a promising target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in CD4-positive alpha-beta cytotoxic T cells overlap with these targets to define a cell-type–specific target set for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CCDC26', 'HAS2', 'NDUFB2', 'THBD', 'AANAT']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB2,"Which gene—CCDC26, HAS2, NDUFB2, THBD, or AANAT—exhibits the highest cell-type-specific expression in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene—CCDC26, HAS2, NDUFB2, THBD, or AANAT—exhibits the highest cell-type-specific expression in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the cd4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE to define the follicular lymphoma–specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AP1M1', 'RPL29P4', 'NDUFB10', 'CD6', 'CD207']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB10,"Among AP1M1, RPL29P4, NDUFB10, CD6, and CD207, which gene exhibits the highest cell-type specificity in CD4+ αβ cytotoxic T cells for the targeted treatment of follicular lymphoma?","Among AP1M1, RPL29P4, NDUFB10, CD6, and CD207, which gene exhibits the highest cell-type specificity in CD4+ αβ cytotoxic T cells for the targeted treatment of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of genes activated in CD4-positive αβ cytotoxic T cells in PINNACLE to define cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these overlapping genes, then compute the cosine similarity between this average and the embedding of each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYB5R1', 'TOP2A', 'PHPT1', 'VPREB1', 'ST6GALNAC2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TOP2A,"Which gene among CYB5R1, TOP2A, PHPT1, VPREB1, and ST6GALNAC2 exhibits the highest cell-type specificity in CD4-positive, alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among CYB5R1, TOP2A, PHPT1, VPREB1, and ST6GALNAC2 exhibits the highest cell-type specificity in CD4-positive, alpha-beta cytotoxic T cells for targeting follicular lymphoma? Retrieve the cell-type–specific embeddings for the verified therapeutic targets of follicular lymphoma from the PINNACLE database. Next, identify the overlap between these targets and the genes activated in CD4-positive alpha-beta cytotoxic T cells. For the overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDK4', 'CCR2', 'TLN2', 'APC2', 'GAL3ST1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,CDK4,"Which gene among CDK4, CCR2, TLN2, APC2, and GAL3ST1 exhibits the highest expression specificity in CD4-positive alpha-beta cytotoxic T cells that target follicular lymphoma?","Which gene among CDK4, CCR2, TLN2, APC2, and GAL3ST1 exhibits the highest expression specificity in CD4-positive alpha-beta cytotoxic T cells that target follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE, defining this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set and then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher cosine similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TUBB', 'PPM1D', 'HIP1R', 'ZNF317', 'TLCD1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TUBB,"Which gene among TUBB, PPM1D, HIP1R, ZNF317, and TLCD1 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among TUBB, PPM1D, HIP1R, ZNF317, and TLCD1 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of genes activated in CD4-positive alpha-beta cytotoxic T cells. Calculate the average embedding of the overlapping genes as a reference, then derive the cosine similarity between this reference and each individual target’s embedding. If one gene demonstrates a significantly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB3', 'IL34', 'PABPN1', 'GAL3ST3', 'SNX24']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB3,"Among the genes NDUFB3, IL34, PABPN1, GAL3ST3, and SNX24, which one exhibits the greatest expression specificity in CD4-positive alpha-beta cytotoxic T cells, thereby representing the most promising candidate for targeted follicular lymphoma therapy?","Among the genes NDUFB3, IL34, PABPN1, GAL3ST3, and SNX24, which one exhibits the greatest expression specificity in CD4-positive alpha-beta cytotoxic T cells, thereby representing the most promising candidate for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the cd4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE; this overlapping set defines the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CETP', 'HLA-DRB1', 'RHBG', 'LCT', 'TARDBP']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,HLA-DRB1,"Among CETP, HLA-DRB1, RHBG, LCT, and TARDBP, which gene demonstrates the greatest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma?","Among CETP, HLA-DRB1, RHBG, LCT, and TARDBP, which gene demonstrates the greatest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in CD4-positive alpha-beta cytotoxic T cells in PINNACLE to establish a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set and then calculate the cosine similarity between this average and each individual target gene's embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ILF2', 'RBX1', 'NRSN2', 'TXN2', 'FECH']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,RBX1,"Among the genes ILF2, RBX1, NRSN2, TXN2, and FECH, which one exhibits the highest cell-type-specific expression in CD4-positive alpha-beta T cells for targeted follicular lymphoma therapy?","Among the genes ILF2, RBX1, NRSN2, TXN2, and FECH, which one exhibits the highest cell-type-specific expression in CD4-positive alpha-beta T cells for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma available in the PINNACLE database and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with genes expressed in CD4-positive alpha-beta cytotoxic T cells. Using the overlapping genes, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. Finally, select the gene with the highest similarity as the primary candidate and provide a concise, evidence-based rationale for its biological significance."
"['CLDND2', 'PKN3', 'NDUFA6', 'NOTCH4', 'DUS2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA6,"Among the genes CLDND2, PKN3, NDUFA6, NOTCH4, and DUS2, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes CLDND2, PKN3, NDUFA6, NOTCH4, and DUS2, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma by retrieving their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with CD4-positive alpha-beta cytotoxic T cell–activated genes in the PINNACLE dataset to define the follicular lymphoma cell-type specific targets. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LCK', 'WNK2', 'MAP4K3', 'FAM135A', 'NBEA']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,LCK,"Among LCK, WNK2, MAP4K3, FAM135A, and NBEA, which gene exhibits the highest cell-type specific expression in CD4-positive alpha‐beta cytotoxic T cells, making it the most promising candidate for targeted therapy of follicular lymphoma?","Among LCK, WNK2, MAP4K3, FAM135A, and NBEA, which gene exhibits the highest cell-type specific expression in CD4-positive alpha‐beta cytotoxic T cells, making it the most promising candidate for targeted therapy of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the embeddings of activated cd4-positive alpha-beta cytotoxic T cells. Compute the average embedding for the overlapping gene set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AKR7A3', 'NME1', 'PECR', 'TYK2', 'SCN8A']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TYK2,"Which gene among AKR7A3, NME1, PECR, TYK2, and SCN8A exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma?","Which gene among AKR7A3, NME1, PECR, TYK2, and SCN8A exhibits the highest cell-type specificity in CD4-positive αβ cytotoxic T cells for targeting follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Identify the genes that overlap with the cd4-positive alpha-beta cytotoxic T cell-activated genes from PINNACLE; these constitute the follicular lymphoma cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FKBP1A', 'CDH15', 'DPYSL2', 'ELOVL6', 'IGLV3-25']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,FKBP1A,"Which gene among FKBP1A, CDH15, DPYSL2, ELOVL6, and IGLV3-25 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among FKBP1A, CDH15, DPYSL2, ELOVL6, and IGLV3-25 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TAFA1', 'LAG3', 'RHOH', 'ICAM1', 'FAHD1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,LAG3,"Which gene—TAFA1, LAG3, RHOH, ICAM1, or FAHD1—exhibits the highest cell-type specificity in CD4-positive, αβ cytotoxic T cells for targeting follicular lymphoma?","Which gene—TAFA1, LAG3, RHOH, ICAM1, or FAHD1—exhibits the highest cell-type specificity in CD4-positive, αβ cytotoxic T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma using PINNACLE and retrieve their corresponding cell-type–specific embeddings. Next, determine the intersection between these targets and the cd4-positive alpha-beta cytotoxic T cell-activated gene set available in PINNACLE. Compute the average embedding of the overlapping genes as a reference, then calculate the cosine similarity between this average and each individual gene embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TCHP', 'MDH1B', 'DRD5', 'ZNF804A', 'NDUFS6']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFS6,"Which gene among TCHP, MDH1B, DRD5, ZNF804A, and NDUFS6 shows the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among TCHP, MDH1B, DRD5, ZNF804A, and NDUFS6 shows the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE. Using this overlapping set as the follicular lymphoma targets, compute their average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TAX1BP1', 'NDUFB9', 'USH1G', 'VGF', 'CYTOR']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB9,"Among the genes TAX1BP1, NDUFB9, USH1G, VGF, and CYTOR, which shows the highest cell type-specific expression in CD4-positive αβ T cells for potential targeting of follicular lymphoma?","Among the genes TAX1BP1, NDUFB9, USH1G, VGF, and CYTOR, which shows the highest cell type-specific expression in CD4-positive αβ T cells for potential targeting of follicular lymphoma? Retrieve the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set and determine the cosine similarity between this reference embedding and that of each individual target gene. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IER3', 'PHETA2', 'DPYSL5', 'LMO4', 'NDUFS8']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFS8,"Which gene—IER3, PHETA2, DPYSL5, LMO4, or NDUFS8—demonstrates the greatest cell-type specificity in CD4-positive αβ cytotoxic T cells for potential targeting of follicular lymphoma?","Which gene—IER3, PHETA2, DPYSL5, LMO4, or NDUFS8—demonstrates the greatest cell-type specificity in CD4-positive αβ cytotoxic T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE, and compute the average embedding for this overlapping set. Finally, calculate the cosine similarity between this average embedding and each individual target embedding; if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CLPP', 'AMN', 'PRKCB', 'INHBB', 'POP1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,PRKCB,"Which gene among CLPP, AMN, PRKCB, INHBB, and POP1 exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among CLPP, AMN, PRKCB, INHBB, and POP1 exhibits the highest specificity for CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE; this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set and calculate the cosine similarity between this reference embedding and that of each individual gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['ADAM22', 'KLF15', 'FRG1', 'NDUFA10', 'BMP2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA10,"Among the genes ADAM22, KLF15, FRG1, NDUFA10, and BMP2, which shows the most cell-type-specific expression in CD4-positive alpha-beta cytotoxic T cells employed for targeting follicular lymphoma?","Among the genes ADAM22, KLF15, FRG1, NDUFA10, and BMP2, which shows the most cell-type-specific expression in CD4-positive alpha-beta cytotoxic T cells employed for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which cd4-positive alpha-beta cytotoxic T cell‐activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits significantly higher similarity than all others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CYB5R1', 'RAB11FIP3', 'MYEF2', 'NDUFV1', 'DNAJC13']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFV1,"Which gene among CYB5R1, RAB11FIP3, MYEF2, NDUFV1, and DNAJC13 exhibits the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among CYB5R1, RAB11FIP3, MYEF2, NDUFV1, and DNAJC13 exhibits the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the CD4-positive alpha-beta cytotoxic T cell-activated genes represented in PINNACLE. Compute the average embedding for this overlapping gene set, and then calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NUP107', 'SVOP', 'NDUFC2', 'TMEM131', 'ETS2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFC2,"Which gene among NUP107, SVOP, NDUFC2, TMEM131, and ETS2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among NUP107, SVOP, NDUFC2, TMEM131, and ETS2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the intersection between these targets and the naive thymus-derived CD4-positive alpha-beta T cell-activated genes cataloged in PINNACLE. For this overlapping gene set, calculate the average embedding as a reference vector and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in follicular lymphoma."
"['C17orf50', 'PRKAA2', 'SERF2', 'INIP', 'NDUFC1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFC1,"Which gene among C17orf50, PRKAA2, SERF2, INIP, and NDUFC1 exhibits the highest specificity for naive, thymus-derived, CD4-positive αβ T cells in the context of targeting follicular lymphoma?","Which gene among C17orf50, PRKAA2, SERF2, INIP, and NDUFC1 exhibits the highest specificity for naive, thymus-derived, CD4-positive αβ T cells in the context of targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Next, determine which genes among the naive thymus-derived CD4-positive αβ T cell-activated set in PINNACLE overlap with these targets. Calculate the average embedding for the overlapping genes as a reference, then compute the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate therapeutic target and provide a concise, evidence-based rationale for its biological relevance."
"['MSL3', 'MAFA', 'LCP1', 'ZDHHC11', 'TUBB']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,TUBB,"Among the candidate genes MSL3, MAFA, LCP1, ZDHHC11, and TUBB, which exhibits the highest cell-type specificity in naïve, thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Among the candidate genes MSL3, MAFA, LCP1, ZDHHC11, and TUBB, which exhibits the highest cell-type specificity in naïve, thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE. Using this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale supporting its biological relevance."
"['GYPC', 'CENPU', 'NDUFA2', 'EVX2', 'OLIG2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA2,"Which gene among GYPC, CENPU, NDUFA2, EVX2, and OLIG2 shows the highest specificity in naive, thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among GYPC, CENPU, NDUFA2, EVX2, and OLIG2 shows the highest specificity in naive, thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma? Using PINNACLE, identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the naive thymus-derived CD4-positive alpha-beta T cell-activated genes, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPRR1B', 'KRTAP5-1', 'STRBP', 'HTR4', 'TOP2B']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,TOP2B,"Which gene—SPRR1B, KRTAP5-1, STRBP, HTR4, or TOP2B—exhibits the highest cell-type specificity in naive, thymus-derived CD4-positive αβ T cells for targeting follicular lymphoma?","Which gene—SPRR1B, KRTAP5-1, STRBP, HTR4, or TOP2B—exhibits the highest cell-type specificity in naive, thymus-derived CD4-positive αβ T cells for targeting follicular lymphoma? Retrieve the verified therapeutic targets for follicular lymphoma from PINNACLE and identify the overlapping genes with the naive thymus-derived, CD4-positive, αβ T cell-activated gene set. Using the cell-type–specific embeddings from PINNACLE, calculate the average embedding for these overlapping genes as a reference. Next, compute the cosine similarity between this reference and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MBLAC2', 'DNMT1', 'MAGEB6', 'SLC9A1', 'TTC39A']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,DNMT1,"Which gene among MBLAC2, DNMT1, MAGEB6, SLC9A1, and TTC39A exhibits the highest cell type-specific expression in naive thymus-derived CD4-positive alpha-beta T cells, thereby representing the most promising target for follicular lymphoma?","Which gene among MBLAC2, DNMT1, MAGEB6, SLC9A1, and TTC39A exhibits the highest cell type-specific expression in naive thymus-derived CD4-positive alpha-beta T cells, thereby representing the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes associated with naive thymus-derived, CD4-positive, alpha-beta T cell activation in PINNACLE. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between the reference and each target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LHFPL3', 'NDUFA5', 'MRPS31', 'RNF8', 'RUSF1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA5,"Among the genes LHFPL3, NDUFA5, MRPS31, RNF8, and RUSF1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for follicular lymphoma?","Among the genes LHFPL3, NDUFA5, MRPS31, RNF8, and RUSF1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD4-positive alpha-beta T cell activation gene set from PINNACLE. Compute the average embedding of this common set as a reference, then calculate the cosine similarity between this reference and each target gene's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its relevance in follicular lymphoma."
"['C10orf62', 'PPP1R12C', 'NAA50', 'NDUFS4', 'C1orf105']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS4,"Which gene among C10orf62, PPP1R12C, NAA50, NDUFS4, and C1orf105 shows the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing the optimal target for follicular lymphoma?","Which gene among C10orf62, PPP1R12C, NAA50, NDUFS4, and C1orf105 shows the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing the optimal target for follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes associated with naive thymus-derived CD4-positive alpha-beta T cell activation in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlap as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BORCS5', 'NDUFS6', 'SPTBN2', 'WASHC2C', 'MCM8']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS6,"Which gene among BORCS5, NDUFS6, SPTBN2, WASHC2C, and MCM8 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among BORCS5, NDUFS6, SPTBN2, WASHC2C, and MCM8 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the naive thymus-derived CD4+ alpha-beta T cell–activated genes in PINNACLE overlap with these targets. Calculate the average embedding for this overlapping set and then compute the cosine similarity between the average and each individual target. If one gene shows a significantly higher similarity than the others, designate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TTLL7', 'CCNYL1', 'LHX6', 'PROX1', 'NDUFB11']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFB11,"Among the genes TTLL7, CCNYL1, LHX6, PROX1, and NDUFB11, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Among the genes TTLL7, CCNYL1, LHX6, PROX1, and NDUFB11, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus‐derived CD4-positive αβ T cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SEC61B', 'FGD5', 'DTX3', 'NCOA1', 'MCL1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,MCL1,"Among the genes SEC61B, FGD5, DTX3, NCOA1, and MCL1, which one exhibits the highest expression specificity in naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma?","Among the genes SEC61B, FGD5, DTX3, NCOA1, and MCL1, which one exhibits the highest expression specificity in naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naïve thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set and then compute the cosine similarity between this reference and each individual target embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PGP', 'HDAC7', 'PDE4A', 'ITIH6', 'PRKCZ']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,HDAC7,"Which gene—PGP, HDAC7, PDE4A, ITIH6, or PRKCZ—displays the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells for potential targeted therapies in follicular lymphoma?","Which gene—PGP, HDAC7, PDE4A, ITIH6, or PRKCZ—displays the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells for potential targeted therapies in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the naive, thymus-derived, CD4-positive alpha-beta T cell‐activated genes in PINNACLE. Calculate the average embedding for the overlapping gene set and compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GAK', 'CERK', 'HCLS1', 'MIP', 'NDUFAF4']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFAF4,"Which gene among GAK, CERK, HCLS1, MIP, and NDUFAF4 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among GAK, CERK, HCLS1, MIP, and NDUFAF4 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, from the set of naive thymus-derived, CD4-positive, alpha-beta T cell–activated genes in PINNACLE, determine the overlap with these targets—this overlapping gene set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SLC7A10', 'GLA', 'TRAPPC10', 'NDUFV1', 'ECHDC2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFV1,"Among the genes SLC7A10, GLA, TRAPPC10, NDUFV1, and ECHDC2, which exhibits the highest cell-type specificity in naive, thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes SLC7A10, GLA, TRAPPC10, NDUFV1, and ECHDC2, which exhibits the highest cell-type specificity in naive, thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes from the naïve thymus–derived, CD4-positive, alpha-beta T cell–activated gene set in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate this gene as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['CAB39L', 'PSME1', 'CD79B', 'PPP1CB', 'FAM76B']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CD79B,"Among the genes CAB39L, PSME1, CD79B, PPP1CB, and FAM76B, which exhibits the most specific expression in naive thymus-derived CD4+ αβ T cells for potential targeting of follicular lymphoma?","Among the genes CAB39L, PSME1, CD79B, PPP1CB, and FAM76B, which exhibits the most specific expression in naive thymus-derived CD4+ αβ T cells for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the naive, thymus-derived, CD4-positive, αβ T cell‐activated genes in PINNACLE overlap with these therapeutic targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PRNP', 'AVP', 'SMARCC1', 'NDUFA1', 'UROS']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA1,"Among PRNP, AVP, SMARCC1, NDUFA1, and UROS, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for the targeting of follicular lymphoma?","Among PRNP, AVP, SMARCC1, NDUFA1, and UROS, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for the targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, from the naive thymus-derived CD4-positive alpha-beta T cell signature in PINNACLE, identify the genes that overlap with these targets. Compute the average embedding for the overlapping set and calculate the cosine similarity of each individual target embedding to this average. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UTP25', 'PSMB5', 'SYN3', 'ACBD5', 'PCSK5']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,PSMB5,"Which gene among UTP25, PSMB5, SYN3, ACBD5, and PCSK5 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Which gene among UTP25, PSMB5, SYN3, ACBD5, and PCSK5 exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type-specific embeddings from the PINNACLE database. Then, determine which genes—specifically those that are naive thymus-derived, CD4-positive, alpha-beta T cell-activated—in PINNACLE overlap with these targets, thereby defining a set of cell-type-specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CD3D', 'HAUS4', 'USP36', 'BAZ1B', 'TBC1D15']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CD3D,"Which gene among CD3D, HAUS4, USP36, BAZ1B, and TBC1D15 exhibits the highest specificity in naive thymus‐derived CD4-positive αβ T cells for targeting follicular lymphoma?","Which gene among CD3D, HAUS4, USP36, BAZ1B, and TBC1D15 exhibits the highest specificity in naive thymus‐derived CD4-positive αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the set of naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE; this overlapping set represents the cell-type–specific targets relevant to follicular lymphoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KLHL23', 'CRBN', 'PLD2', 'UCP3', 'TNFRSF12A']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CRBN,"Among the candidate genes KLHL23, CRBN, PLD2, UCP3, and TNFRSF12A, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma?","Among the candidate genes KLHL23, CRBN, PLD2, UCP3, and TNFRSF12A, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of naïve, thymus-derived, CD4-positive, αβ T cell-activated genes available in PINNACLE; this overlapping gene set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlap as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND4', 'ZNF438', 'HCFC1R1', 'MAGEA2B', 'NME1-NME2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,MT-ND4,"Which gene among MT-ND4, ZNF438, HCFC1R1, MAGEA2B, and NME1-NME2 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma?","Which gene among MT-ND4, ZNF438, HCFC1R1, MAGEA2B, and NME1-NME2 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embedding vectors from the PINNACLE dataset. Identify which of these targets overlap with the naive thymus–derived CD4-positive alpha–beta T cell activation gene set in PINNACLE. Using the overlapping genes' embeddings, calculate the average embedding vector as a reference, then compute the cosine similarity between this reference and each individual target vector. If one gene exhibits a markedly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['H2AC13', 'BBS4', 'LHPP', 'FXR2', 'NDUFA4']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFA4,"Which gene among H2AC13, BBS4, LHPP, FXR2, and NDUFA4 exhibits the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells for targeted intervention in follicular lymphoma?","Which gene among H2AC13, BBS4, LHPP, FXR2, and NDUFA4 exhibits the highest cell-type specificity in naive, thymus-derived CD8+ αβ T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD8-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets to form a subset of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this subset as a reference, and then calculate the cosine similarity between this reference and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAB1', 'RGMA', 'ZNF697', 'IL18', 'ANKRD26P1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFAB1,"Among the genes NDUFAB1, RGMA, ZNF697, IL18, and ANKRD26P1, which exhibits the most cell-type specific expression in naive thymus-derived CD8+ alpha-beta T cells, thereby representing the best candidate for targeting follicular lymphoma?","Among the genes NDUFAB1, RGMA, ZNF697, IL18, and ANKRD26P1, which exhibits the most cell-type specific expression in naive thymus-derived CD8+ alpha-beta T cells, thereby representing the best candidate for targeting follicular lymphoma? Using the verified therapeutic targets for follicular lymphoma from PINNACLE, extract their cell-type–specific embeddings. Then, identify the intercellular overlap between these targets and the naive thymus-derived CD8-positive alpha-beta T cell-activated genes available in PINNACLE. Compute the average embedding of the overlapping gene set and determine the cosine similarity between this reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TLR2', 'KHDRBS3', 'ZNF660', 'U2AF1', 'FYN']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,FYN,"Among the genes TLR2, KHDRBS3, ZNF660, U2AF1, and FYN, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes TLR2, KHDRBS3, ZNF660, U2AF1, and FYN, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, from the genes associated with naive thymus‐derived, CD8-positive, alpha-beta T cell activation in PINNACLE, determine which genes overlap with these targets. Using this overlapping set as the cell-type–specific targets for follicular lymphoma, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FCRL3', 'TEAD2', 'LRRC45', 'CELF2', 'HECTD1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,CELF2,"Which gene among FCRL3, TEAD2, LRRC45, CELF2, and HECTD1 demonstrates the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Which gene among FCRL3, TEAD2, LRRC45, CELF2, and HECTD1 demonstrates the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Using verified therapeutic targets for follicular lymphoma and their corresponding cell-type–specific embeddings from PINNACLE, identify the subset that overlaps with naive thymus-derived CD8-positive alpha-beta T cell–activated genes in PINNACLE. Compute the average embedding for these overlapping targets and then calculate the cosine similarity between this reference and each individual embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDRT4', 'NDUFB4', 'SLC7A11', 'IL36RN', 'SPIRE1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB4,"Among the genes CDRT4, NDUFB4, SLC7A11, IL36RN, and SPIRE1, which exhibits the greatest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising target for follicular lymphoma intervention?","Among the genes CDRT4, NDUFB4, SLC7A11, IL36RN, and SPIRE1, which exhibits the greatest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby representing the most promising target for follicular lymphoma intervention? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with naive thymus-derived CD8+ αβ T cell–activated genes in PINNACLE. Compute the average embedding for the overlapping gene set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDS5B', 'NDUFS5', 'FAM27E3', 'APOBEC3A', 'CASP9']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS5,"Which gene—PDS5B, NDUFS5, FAM27E3, APOBEC3A, or CASP9—displays the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma?","Which gene—PDS5B, NDUFS5, FAM27E3, APOBEC3A, or CASP9—displays the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma? Using the PINNACLE dataset, identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings. Next, intersect these targets with the gene set corresponding to activated naive thymus-derived cd8-positive alpha-beta T cells, also from PINNACLE. Compute the average embedding of the overlapping genes and then calculate the cosine similarity between this average and the embedding of each individual gene. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['TRMT10A', 'NDUFS7', 'LONRF2', 'SERINC1', 'RBPMS2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS7,"Which gene among TRMT10A, NDUFS7, LONRF2, SERINC1, and RBPMS2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby serving as the most promising target for follicular lymphoma?","Which gene among TRMT10A, NDUFS7, LONRF2, SERINC1, and RBPMS2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, thereby serving as the most promising target for follicular lymphoma? Identify experimentally validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the naive, thymus-derived, CD8-positive αβ T cell-activated genes in PINNACLE overlap with these targets. Using the overlapping gene set, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GABRD', 'RNF122', 'NDUFV2', 'MAP4K2', 'PAGE1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFV2,"Among the genes GABRD, RNF122, NDUFV2, MAP4K2, and PAGE1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Among the genes GABRD, RNF122, NDUFV2, MAP4K2, and PAGE1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of the naive thymus-derived CD8-positive αβ T cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding for this intersecting gene set. Calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IL2RB', 'ATG16L2', 'TMEM120B', 'TIE1', 'EIF5A']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,IL2RB,"Which gene among IL2RB, ATG16L2, TMEM120B, TIE1, and EIF5A exhibits the most cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among IL2RB, ATG16L2, TMEM120B, TIE1, and EIF5A exhibits the most cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Using PINNACLE, identify the confirmed therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings. Then, determine the overlap between these targets and the genes activated in naive thymus-derived CD8+ αβ T cells, defining a set of follicular lymphoma cell-type–specific targets. Compute the average embedding for this set as a reference, and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['UGT2B4', 'PFKM', 'AZGP1', 'HSP90AA1', 'GSTM3']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AA1,"Which gene among UGT2B4, PFKM, AZGP1, HSP90AA1, and GSTM3 shows the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among UGT2B4, PFKM, AZGP1, HSP90AA1, and GSTM3 shows the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive thymus-derived CD8-positive alpha-beta T cell–activated genes in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['COL20A1', 'PPIA', 'STAC', 'MRPL49', 'MTHFS']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,PPIA,"Which gene among COL20A1, PPIA, STAC, MRPL49, and MTHFS exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting of follicular lymphoma?","Which gene among COL20A1, PPIA, STAC, MRPL49, and MTHFS exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, from the gene set associated with activated naive thymus–derived CD8+ αβ T cells in PINNACLE, determine which genes overlap with these targets. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this composite embedding and each individual target embedding. Finally, nominate the gene with the highest similarity as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MT-ND4L', 'IFNA1', 'FCER1G', 'BRD2', 'ARMC1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND4L,"Among the genes MT-ND4L, IFNA1, FCER1G, BRD2, and ARMC1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma?","Among the genes MT-ND4L, IFNA1, FCER1G, BRD2, and ARMC1, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most suitable candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the genes that overlap between these targets and the naive thymus-derived CD8-positive αβ T cell activation gene set in PINNACLE. For the overlapping set, calculate the average embedding as a reference vector, then compute the cosine similarity between this reference vector and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SFXN1', 'AQP9', 'HLA-DMB', 'HSP90AB1', 'DROSHA']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AB1,"Which gene among SFXN1, AQP9, HLA-DMB, HSP90AB1, and DROSHA shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among SFXN1, AQP9, HLA-DMB, HSP90AB1, and DROSHA shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma using PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the naive thymus-derived CD8-positive alpha-beta T cell-activated genes in PINNACLE. Using the overlapping set as the cell-type–specific targets for follicular lymphoma, compute their average embedding as a reference. Then, calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPP4R1', 'SEMA3A', 'NUDT6', 'INTS13', 'NDUFB10']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB10,"Which gene among PPP4R1, SEMA3A, NUDT6, INTS13, and NDUFB10 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among PPP4R1, SEMA3A, NUDT6, INTS13, and NDUFB10 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the naive thymus–derived CD8+ αβ T cell–activated genes found in PINNACLE. Calculate the average embedding of the overlapping gene set to serve as a reference, then compute the cosine similarity between this reference and each individual target embedding. If a single gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['USP47', 'PDC', 'KEL', 'MT-ND3', 'NET1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND3,"Which gene among USP47, PDC, KEL, MT-ND3, and NET1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among USP47, PDC, KEL, MT-ND3, and NET1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma in PINNACLE and obtain their cell-type–specific embeddings. Next, identify the overlap between these targets and the naive thymus-derived CD8-positive alpha-beta T cell-activated genes in PINNACLE. Calculate the average embedding of the overlapping genes as a reference, and then determine the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS7', 'OGDHL', 'CLCN1', 'CACNA1F', 'ZBTB1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS7,"Which gene among NDUFS7, OGDHL, CLCN1, CACNA1F, and ZBTB1 exhibits the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among NDUFS7, OGDHL, CLCN1, CACNA1F, and ZBTB1 exhibits the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of activated genes from naive thymus-derived CD8-positive αβ T cells in PINNACLE. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and the embedding of each target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PTBP2', 'NDUFS5', 'CLTRN', 'BCAR1', 'PHKA1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS5,"Among the genes PTBP2, NDUFS5, CLTRN, BCAR1, and PHKA1, which shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes PTBP2, NDUFS5, CLTRN, BCAR1, and PHKA1, which shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive, thymus-derived, CD8-positive, alpha-beta T cell–activated genes from PINNACLE. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZFP3', 'GLA', 'STMN4', 'TRMT10A', 'HSP90AA1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AA1,"Which gene among ZFP3, GLA, STMN4, TRMT10A, and HSP90AA1 exhibits the highest specificity of expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among ZFP3, GLA, STMN4, TRMT10A, and HSP90AA1 exhibits the highest specificity of expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive, thymus-derived, CD8-positive, alpha-beta T cell–activated genes in PINNACLE to define a subset specific for follicular lymphoma. Compute the average embedding for this subset and assess the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TUG1', 'SLC13A3', 'MT-ND3', 'DLEU1', 'CERKL']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND3,"Among the genes TUG1, SLC13A3, MT-ND3, DLEU1, and CERKL, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for follicular lymphoma targeting?","Among the genes TUG1, SLC13A3, MT-ND3, DLEU1, and CERKL, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for follicular lymphoma targeting? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of naive thymus-derived, CD8+ alpha-beta T-cell–activated genes in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this average and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHISAL2A', 'FBN2', 'NGLY1', 'NDUFA4', 'DDX58']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFA4,"Which gene among SHISAL2A, FBN2, NGLY1, NDUFA4, and DDX58 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, thereby representing a promising target for follicular lymphoma?","Which gene among SHISAL2A, FBN2, NGLY1, NDUFA4, and DDX58 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, thereby representing a promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the naive thymus-derived CD8-positive alpha-beta T cell-activated genes in PINNACLE; the overlapping set constitutes the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC1', 'HS3ST1', 'FLI1', 'PROKR2', 'SYT15']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HDAC1,"Which gene among HDAC1, HS3ST1, FLI1, PROKR2, and SYT15 demonstrates the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among HDAC1, HS3ST1, FLI1, PROKR2, and SYT15 demonstrates the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the experimentally validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with effector CD8-positive αβ T cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WIPF3', 'CELSR2', 'BCL2A1', 'RHAG', 'SH3YL1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,BCL2A1,"Among the genes WIPF3, CELSR2, BCL2A1, RHAG, and SH3YL1, which one demonstrates the highest cell-type specificity in effector CD8+ αβ T cells, making it the most appropriate candidate for targeting follicular lymphoma?","Among the genes WIPF3, CELSR2, BCL2A1, RHAG, and SH3YL1, which one demonstrates the highest cell-type specificity in effector CD8+ αβ T cells, making it the most appropriate candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in effector CD8-positive alpha-beta T cells, as defined in PINNACLE. Compute the average embedding for the overlapping genes and calculate the cosine similarity between this average embedding and the embedding for each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HSPE1', 'BAG6', 'NDUFV2', 'VEZF1', 'WEE1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFV2,"Which gene among HSPE1, BAG6, NDUFV2, VEZF1, and WEE1 demonstrates the most specific expression profile in effector CD8+ alpha-beta T cells relevant to follicular lymphoma targeting?","Which gene among HSPE1, BAG6, NDUFV2, VEZF1, and WEE1 demonstrates the most specific expression profile in effector CD8+ alpha-beta T cells relevant to follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the activated effector CD8+ αβ T-cell genes in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['OTUD3', 'ZFP36', 'CD28', 'NDUFS7', 'GOLGA2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFS7,"Which gene among OTUD3, ZFP36, CD28, NDUFS7, and GOLGA2 exhibits the highest expression specificity in effector CD8-positive alpha-beta T cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among OTUD3, ZFP36, CD28, NDUFS7, and GOLGA2 exhibits the highest expression specificity in effector CD8-positive alpha-beta T cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which effector CD8-positive αβ T cell activation genes in PINNACLE overlap with these targets to define a cell-type–specific target set for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYP1A1', 'DUSP21', 'MS4A1', 'ELMOD2', 'SART1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MS4A1,"Among the genes CYP1A1, DUSP21, MS4A1, ELMOD2, and SART1, which one shows the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma?","Among the genes CYP1A1, DUSP21, MS4A1, ELMOD2, and SART1, which one shows the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which effector CD8+ alpha-beta T cell-activated genes from PINNACLE overlap with these targets, thereby forming a candidate set. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC3', 'SPRING1', 'ATXN7L1', 'SCNN1D', 'STK16']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HDAC3,"Among HDAC3, SPRING1, ATXN7L1, SCNN1D, and STK16, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Among HDAC3, SPRING1, ATXN7L1, SCNN1D, and STK16, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in effector CD8-positive αβ T cells overlap with these targets to define the follicular lymphoma-specific set. Calculate the average embedding of this overlapping set, then compute the cosine similarity between the average embedding and each individual target’s embedding. If a single gene exhibits markedly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HMGA1', 'MBD3L3', 'NDUFS3', 'SUCO', 'KMT2C']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFS3,"Among HMGA1, MBD3L3, NDUFS3, SUCO, and KMT2C, which gene exhibits the highest expression specificity in effector CD8+ αβ T cells implicated in targeting follicular lymphoma?","Among HMGA1, MBD3L3, NDUFS3, SUCO, and KMT2C, which gene exhibits the highest expression specificity in effector CD8+ αβ T cells implicated in targeting follicular lymphoma? For follicular lymphoma, identify the validated therapeutic targets and extract their cell-type-specific embeddings from the PINNACLE database. Next, from PINNACLE, select the effector CD8+ αβ T cell-activated genes and determine their overlap with the set of lymphoma targets. Using this common set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and the embedding of each individual gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DNMT1', 'TIMM29', 'TH', 'ORMDL3', 'PTPN20']",follicular lymphoma,effector cd8-positive alpha-beta t cell,DNMT1,"Which gene among DNMT1, TIMM29, TH, ORMDL3, and PTPN20 exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among DNMT1, TIMM29, TH, ORMDL3, and PTPN20 exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which effector CD8-positive αβ T cell-activated genes in PINNACLE also appear among these targets, forming the cell-type–specific target set for follicular lymphoma. Compute the average embedding of this set and calculate the cosine similarity between this average and the individual gene embeddings. If one gene demonstrates a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['UVRAG', 'RCVRN', 'SUV39H2', 'NDUFAF3', 'RSRP1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFAF3,"Which gene among UVRAG, RCVRN, SUV39H2, NDUFAF3, and RSRP1 exhibits the highest specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma?","Which gene among UVRAG, RCVRN, SUV39H2, NDUFAF3, and RSRP1 exhibits the highest specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, find the overlap between these targets and the activated, effector CD8+ alpha-beta T cell genes available in PINNACLE. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between the average embedding and each individual target gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['HLA-DRB5', 'NCOA5', 'UBE2E2', 'TDRD1', 'GFUS']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HLA-DRB5,"Which gene among HLA-DRB5, NCOA5, UBE2E2, TDRD1, and GFUS exhibits the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma?","Which gene among HLA-DRB5, NCOA5, UBE2E2, TDRD1, and GFUS exhibits the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma can be identified from current literature, and what are their corresponding cell-type–specific embeddings from the PINNACLE platform? Among these targets, determine the subset that overlaps with the set of effector CD8⁺ αβ T cell–activated genes in PINNACLE, representing candidate cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this reference vector and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DMTN', 'LRP1', 'SMTN', 'CXCR4', 'DPP10']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CXCR4,"Which gene—DMTN, LRP1, SMTN, CXCR4, or DPP10—exhibits the greatest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene—DMTN, LRP1, SMTN, CXCR4, or DPP10—exhibits the greatest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma from PINNACLE and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with the recognized effector CD8+ alpha-beta T cell activation-associated genes in PINNACLE. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this average and each individual target gene embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB7', 'VASH1', 'DOCK7', 'XRCC1', 'EFS']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB7,"Which gene among NDUFB7, VASH1, DOCK7, XRCC1, and EFS shows the highest specificity in effector CD8+ αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma?","Which gene among NDUFB7, VASH1, DOCK7, XRCC1, and EFS shows the highest specificity in effector CD8+ αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and PINNACLE’s set of activated effector CD8-positive alpha-beta T cell genes; this intersecting set comprises the cell-type–specific targets. Compute the average embedding of these overlapping genes as a reference, and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'BATF3', 'MRAP', 'KIF9', 'TONSL']",follicular lymphoma,effector cd8-positive alpha-beta t cell,PPIA,"Which gene among PPIA, BATF3, MRAP, KIF9, and TONSL demonstrates the highest specificity in effector CD8(+) αβ T cells for potential targeting of follicular lymphoma?","Which gene among PPIA, BATF3, MRAP, KIF9, and TONSL demonstrates the highest specificity in effector CD8(+) αβ T cells for potential targeting of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine which activated CD8-positive, alpha-beta T cell effector genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C17orf67', 'FAAP20', 'PRR19', 'SEPTIN12', 'NDUFA5']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA5,"Which gene among C17orf67, FAAP20, PRR19, SEPTIN12, and NDUFA5 exhibits the highest cell-type–specific expression in effector CD8+ αβ T cells for targeted therapy against follicular lymphoma?","Which gene among C17orf67, FAAP20, PRR19, SEPTIN12, and NDUFA5 exhibits the highest cell-type–specific expression in effector CD8+ αβ T cells for targeted therapy against follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE and obtain their cell-type–specific embeddings. Next, determine which of these overlap with effector CD8-positive alpha-beta T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene exhibits noticeably higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RFTN1', 'NDUFA2', 'CLIP4', 'CD177', 'SP2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA2,"Which gene among RFTN1, NDUFA2, CLIP4, CD177, and SP2 shows the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma?","Which gene among RFTN1, NDUFA2, CLIP4, CD177, and SP2 shows the highest specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes shared between these targets and the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE might serve as cell-type–specific targets for the disease. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HSPB1', 'MT-ND4L', 'FIGN', 'SUPV3L1', 'PRPSAP2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MT-ND4L,"Among HSPB1, MT-ND4L, FIGN, SUPV3L1, and PRPSAP2, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for a targeted therapeutic approach to follicular lymphoma?","Among HSPB1, MT-ND4L, FIGN, SUPV3L1, and PRPSAP2, which gene exhibits the highest cell-type specificity in effector CD8+ αβ T cells for a targeted therapeutic approach to follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which CD8-positive, alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['DTX3L', 'NIFK', 'CDK4', 'MYOF', 'SCML1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CDK4,"Among the genes DTX3L, NIFK, CDK4, MYOF, and SCML1, which exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes DTX3L, NIFK, CDK4, MYOF, and SCML1, which exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine the intersection between these targets and the effector CD8-positive alpha-beta T cell activation-associated genes in PINNACLE, thereby defining a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set and compute the cosine similarity between this reference embedding and each individual gene’s embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['FAM153CP', 'TMIE', 'CCL21', 'MCMDC2', 'NDUFB6']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB6,"Among FAM153CP, TMIE, CCL21, MCMDC2, and NDUFB6, which gene exhibits the greatest specificity in effector CD8+ αβ T cells for the targeted treatment of follicular lymphoma?","Among FAM153CP, TMIE, CCL21, MCMDC2, and NDUFB6, which gene exhibits the greatest specificity in effector CD8+ αβ T cells for the targeted treatment of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the activated effector CD8+ alpha-beta T cell genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping gene set as a reference, and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SDS', 'BTBD2', 'RABGAP1', 'ARIH2', 'NDUFS6']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFS6,"Which gene among SDS, BTBD2, RABGAP1, ARIH2, and NDUFS6 exhibits the highest cell type-specific expression in effector CD8+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among SDS, BTBD2, RABGAP1, ARIH2, and NDUFS6 exhibits the highest cell type-specific expression in effector CD8+ αβ T cells, making it the optimal candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the effector CD8-positive αβ T cell–activated genes in PINNACLE, such that the overlapping set forms the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this subset as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LMBR1L', 'HSP90AA1', 'KLF3', 'KLK4', 'POU2AF1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HSP90AA1,"Among the genes LMBR1L, HSP90AA1, KLF3, KLK4, and POU2AF1, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeted therapy of follicular lymphoma?","Among the genes LMBR1L, HSP90AA1, KLF3, KLK4, and POU2AF1, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeted therapy of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the set of effector CD8-positive alpha-beta T cell activation–related genes in PINNACLE to determine the overlapping, cell-type–specific targets. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EZH2', 'KCNIP4', 'CERK', 'NCOA1', 'EI24']",follicular lymphoma,cd8-positive alpha-beta t cell,EZH2,"Which gene among EZH2, KCNIP4, CERK, NCOA1, and EI24 exhibits the highest cell-type specificity in CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among EZH2, KCNIP4, CERK, NCOA1, and EI24 exhibits the highest cell-type specificity in CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Using the PINNACLE dataset, identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the cd8-positive alpha-beta T cell–activated genes in the dataset. For the overlapping genes, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. Finally, nominate the gene with the highest similarity as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['HDAC2', 'CDCA7L', 'IL1A', 'WDR82P1', 'AQP3']",follicular lymphoma,cd8-positive alpha-beta t cell,HDAC2,"Which gene—HDAC2, CDCA7L, IL1A, WDR82P1, or AQP3—exhibits the highest cell-type specificity in CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene—HDAC2, CDCA7L, IL1A, WDR82P1, or AQP3—exhibits the highest cell-type specificity in CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify all therapeutically validated targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection of these targets with the CD8-positive alpha-beta T cell-activated gene set available in PINNACLE to define the follicular lymphoma cell-type–specific targets. Compute the average embedding for this intersecting gene set, and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NDUFB5', 'PLEKHA6', 'PAM', 'POMK', 'SERPINA5']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFB5,"Among the genes NDUFB5, PLEKHA6, PAM, POMK, and SERPINA5, which one shows the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes NDUFB5, PLEKHA6, PAM, POMK, and SERPINA5, which one shows the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the CD8-positive alpha-beta T cell activation genes available in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and assess the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXO28', 'UNC5A', 'ATF2', 'TMEM255B', 'HDAC3']",follicular lymphoma,cd8-positive alpha-beta t cell,HDAC3,"Among the genes FBXO28, UNC5A, ATF2, TMEM255B, and HDAC3, which one exhibits the highest specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes FBXO28, UNC5A, ATF2, TMEM255B, and HDAC3, which one exhibits the highest specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes associated with cd8-positive alpha-beta T cell activation in PINNACLE, treating the intersection as cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MECR', 'BANK1', 'USE1', 'NDUFS7', 'MUC5AC']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFS7,"Which gene among MECR, BANK1, USE1, NDUFS7, and MUC5AC exhibits the highest specificity in CD8-positive αβ T cells, thereby serving as the most promising target for therapy in follicular lymphoma?","Which gene among MECR, BANK1, USE1, NDUFS7, and MUC5AC exhibits the highest specificity in CD8-positive αβ T cells, thereby serving as the most promising target for therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD8-positive αβ T cell–activated genes available in PINNACLE, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PCDHA12', 'RBM15B', 'LINC00663', 'NDUFB3', 'RAB41']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFB3,"Which gene among PCDHA12, RBM15B, LINC00663, NDUFB3, and RAB41 exhibits the highest specificity of expression in CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among PCDHA12, RBM15B, LINC00663, NDUFB3, and RAB41 exhibits the highest specificity of expression in CD8-positive αβ T cells for targeting follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Next, identify which of these targets overlap with the cd8-positive alpha-beta T cell–activated genes in PINNACLE to define the follicular lymphoma cell-type–specific targets. Calculate the average embedding of this overlapping set as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MIEF2', 'EIF4H', 'IMPDH2', 'REV1', 'CCSER1']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH2,"Which gene—MIEF2, EIF4H, IMPDH2, REV1, or CCSER1—displays the highest expression specificity in CD8-positive αβ T cells for potential targeting in follicular lymphoma?","Which gene—MIEF2, EIF4H, IMPDH2, REV1, or CCSER1—displays the highest expression specificity in CD8-positive αβ T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the cd8-positive alpha-beta T cell-activated genes in PINNACLE to define the cell-type-specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between each individual target's embedding and the average embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation for its biological relevance."
"['GRM4', 'CAP1', 'NDUFA10', 'SP8', 'ACTA1']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFA10,"Which gene among GRM4, CAP1, NDUFA10, SP8, and ACTA1 exhibits the highest specificity in CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among GRM4, CAP1, NDUFA10, SP8, and ACTA1 exhibits the highest specificity in CD8+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection of these targets with the cd8-positive, alpha-beta T cell activation genes in PINNACLE, designating the overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding vector for this set and calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DMAC1', 'RPL27', 'SPACA1', 'CEP290', 'TP53']",follicular lymphoma,cd8-positive alpha-beta t cell,TP53,"Among the genes DMAC1, RPL27, SPACA1, CEP290, and TP53, which one exhibits the highest specificity in CD8-positive αβ T cells for targeted follicular lymphoma therapy?","Among the genes DMAC1, RPL27, SPACA1, CEP290, and TP53, which one exhibits the highest specificity in CD8-positive αβ T cells for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS2', 'HES5', 'KIAA0754', 'PLA2G4A', 'RPH3A']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFS2,"Which gene among NDUFS2, HES5, KIAA0754, PLA2G4A, and RPH3A exhibits the highest cell-type specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma?","Which gene among NDUFS2, HES5, KIAA0754, PLA2G4A, and RPH3A exhibits the highest cell-type specificity in CD8-positive αβ T cells for the targeted treatment of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which cd8-positive alpha-beta T cell activation genes from PINNACLE overlap with these targets, defining the cell-type–specific targets for this lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and the individual gene embeddings. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HS3ST2', 'RFC1', 'YES1', 'PRKAR2B', 'SMARCE1']",follicular lymphoma,cd8-positive alpha-beta t cell,YES1,"Which gene among HS3ST2, RFC1, YES1, PRKAR2B, and SMARCE1 exhibits the highest cell-type specificity in CD8+ αβ T cells, making it the optimal candidate for targeted therapy in follicular lymphoma?","Which gene among HS3ST2, RFC1, YES1, PRKAR2B, and SMARCE1 exhibits the highest cell-type specificity in CD8+ αβ T cells, making it the optimal candidate for targeted therapy in follicular lymphoma? Using verified therapeutic targets for follicular lymphoma, obtain their cell-type-specific embeddings from PINNACLE. Next, identify the genes associated with cd8-positive alpha-beta T cell activation in PINNACLE that overlap with these therapeutic targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual gene's embedding. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EMC7', 'TBC1D9', 'IMPDH1', 'UTF1', 'CELSR2']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH1,"Which gene among EMC7, TBC1D9, IMPDH1, UTF1, and CELSR2 exhibits the most restricted expression in CD8+ αβ T cells, making it the best candidate for targeted follicular lymphoma therapy?","Which gene among EMC7, TBC1D9, IMPDH1, UTF1, and CELSR2 exhibits the most restricted expression in CD8+ αβ T cells, making it the best candidate for targeted follicular lymphoma therapy? Using the PINNACLE database, first identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine which of these targets overlap with genes activated in CD8+ αβ T cells. Compute the average embedding of this overlapping set to serve as a reference, and calculate the cosine similarity between the reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['MYT1', 'CCDC150', 'NEUROD1', 'CALCB', 'NDUFB6']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFB6,"Which gene among MYT1, CCDC150, NEUROD1, CALCB, and NDUFB6 displays the highest cell-type specificity in CD8-positive αβ T cells, making it the optimal candidate for targeted follicular lymphoma therapy?","Which gene among MYT1, CCDC150, NEUROD1, CALCB, and NDUFB6 displays the highest cell-type specificity in CD8-positive αβ T cells, making it the optimal candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with the CD8-positive αβ T cell-activated gene set in PINNACLE. Calculate the average embedding of the overlapping genes and use it as a reference to compute the cosine similarity with each individual target’s embedding. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CREBBP', 'MT-ND3', 'ATG12', 'PIK3IP1', 'RPS16']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND3,"Which gene—CREBBP, MT-ND3, ATG12, PIK3IP1, or RPS16—displays the highest cell-type specific expression in CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene—CREBBP, MT-ND3, ATG12, PIK3IP1, or RPS16—displays the highest cell-type specific expression in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. From the subset of activated cd8-positive alpha-beta T cell genes in PINNACLE, determine those that overlap with these targets to define cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLA2', 'PLD3', 'TOR1B', 'FKBP8', 'KRTAP5-3']",follicular lymphoma,cd8-positive alpha-beta t cell,POLA2,"Among the genes POLA2, PLD3, TOR1B, FKBP8, and KRTAP5-3, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes POLA2, PLD3, TOR1B, FKBP8, and KRTAP5-3, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping gene set and compute the cosine similarity between this reference embedding and the embedding of each individual gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CNOT10', 'SLC35B4', 'COLQ', 'LPAR3', 'CDK7']",follicular lymphoma,cd8-positive alpha-beta t cell,CDK7,"Which gene among CNOT10, SLC35B4, COLQ, LPAR3, and CDK7 exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among CNOT10, SLC35B4, COLQ, LPAR3, and CDK7 exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Determine the overlap between these targets and alpha‐beta CD8+ T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, supplying a concise, evidence-based rationale for its biological relevance."
"['C5orf22', 'SLC39A9', 'DDHD1', 'TYK2', 'TBCB']",follicular lymphoma,cd8-positive alpha-beta t cell,TYK2,"Which gene—C5orf22, SLC39A9, DDHD1, TYK2, or TBCB—demonstrates the highest cell-type specificity in CD8+ αβ T cells for targeting follicular lymphoma?","Which gene—C5orf22, SLC39A9, DDHD1, TYK2, or TBCB—demonstrates the highest cell-type specificity in CD8+ αβ T cells for targeting follicular lymphoma? Determine the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, identify which genes among the activated cd8-positive alpha-beta T cell set in PINNACLE overlap with these targets, as these represent the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping gene set, then compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RRP12', 'PLEKHB1', 'IDH3G', 'MT-ND4', 'NSRP1']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND4,"Among the genes RRP12, PLEKHB1, IDH3G, MT-ND4, and NSRP1, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes RRP12, PLEKHB1, IDH3G, MT-ND4, and NSRP1, which one exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets associated with follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the CD8-positive αβ T cell–activated genes in PINNACLE, defining this intersecting set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set to serve as a reference vector, then calculate the cosine similarity between the reference and each individual target’s embedding. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['NRSN2', 'PLG', 'RNF13', 'NDUFA8', 'HIF1A']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFA8,"Which gene—NRSN2, PLG, RNF13, NDUFA8, or HIF1A—exhibits the highest cell-type specificity in CD8+ αβ T cells for follicular lymphoma targeting?","Which gene—NRSN2, PLG, RNF13, NDUFA8, or HIF1A—exhibits the highest cell-type specificity in CD8+ αβ T cells for follicular lymphoma targeting? Which verified therapeutic targets for follicular lymphoma have available cell‐type–specific embeddings in PINNACLE that overlap with the activated gene set of CD8-positive αβ T cells? Identify these overlapping genes as the cell-type–specific targets, compute their average embedding to generate a reference vector, and calculate the cosine similarity between this reference and each target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND5', 'XPO1', 'PRPF40B', 'RNF213', 'CD27']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND5,"Among the genes MT-ND5, XPO1, PRPF40B, RNF213, and CD27, which one shows the highest cell-type specificity in CD8+ αβ T cells for potential targeting of follicular lymphoma?","Among the genes MT-ND5, XPO1, PRPF40B, RNF213, and CD27, which one shows the highest cell-type specificity in CD8+ αβ T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, find the overlap between these targets and the CD8-positive, alpha-beta T cell–activated genes available in PINNACLE. Using the overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a substantially higher similarity score compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SLITRK5', 'GPX7', 'LIFR', 'CCNK', 'NDUFA5']",follicular lymphoma,t follicular helper cell,NDUFA5,"Among the genes SLITRK5, GPX7, LIFR, CCNK, and NDUFA5, which one exhibits the highest cell-type-specific expression in T follicular helper cells relevant to targeting follicular lymphoma?","Among the genes SLITRK5, GPX7, LIFR, CCNK, and NDUFA5, which one exhibits the highest cell-type-specific expression in T follicular helper cells relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are also among the t follicular helper cell-activated genes in PINNACLE, defining this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMEM38B', 'PTRH1', 'NDUFB5', 'CCDC125', 'ANKRD13C']",follicular lymphoma,t follicular helper cell,NDUFB5,"Which gene—TMEM38B, PTRH1, NDUFB5, CCDC125, or ANKRD13C—exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma?","Which gene—TMEM38B, PTRH1, NDUFB5, CCDC125, or ANKRD13C—exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with t follicular helper cell–activated genes in PINNACLE to define the follicular lymphoma cell-type–specific targets. Calculate the average embedding for this overlapping set and then assess the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CENPB', 'HSP90AA1', 'RASGRF2', 'MAGED4', 'BASP1']",follicular lymphoma,t follicular helper cell,HSP90AA1,"Among the genes CENPB, HSP90AA1, RASGRF2, MAGED4, and BASP1, which exhibits the greatest specificity for T follicular helper cells as a potential target in follicular lymphoma?","Among the genes CENPB, HSP90AA1, RASGRF2, MAGED4, and BASP1, which exhibits the greatest specificity for T follicular helper cells as a potential target in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the t follicular helper cell-activated genes in PINNACLE to define the cell-type–specific follicular lymphoma targets. Compute the average embedding of this overlapping set, and calculate the cosine similarity between this reference vector and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['LHX9', 'DNMT3L', 'NDUFV2', 'TRIB2', 'TSPAN7']",follicular lymphoma,t follicular helper cell,NDUFV2,"Among LHX9, DNMT3L, NDUFV2, TRIB2, and TSPAN7, which gene exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Among LHX9, DNMT3L, NDUFV2, TRIB2, and TSPAN7, which gene exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the genes activated by T follicular helper cells in PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity of each individual target embedding to that reference. If one gene shows a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KRTAP12-2', 'CEP57L1P1', 'TFE3', 'POLD2', 'EMP2']",follicular lymphoma,t follicular helper cell,POLD2,"Which gene—KRTAP12-2, CEP57L1P1, TFE3, POLD2, or EMP2—demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene—KRTAP12-2, CEP57L1P1, TFE3, POLD2, or EMP2—demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in T follicular helper cells within PINNACLE overlap with these targets, thereby defining cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping gene set, then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CHML', 'METTL3', 'DHCR7', 'CDK9', 'KCNMB1']",follicular lymphoma,t follicular helper cell,CDK9,"Which gene among CHML, METTL3, DHCR7, CDK9, and KCNMB1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for follicular lymphoma targeting?","Which gene among CHML, METTL3, DHCR7, CDK9, and KCNMB1 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its relevance in follicular lymphoma therapy."
"['CYSRT1', 'SLC17A9', 'PSMB5', 'LGALS9', 'TJP2']",follicular lymphoma,t follicular helper cell,PSMB5,"Which gene among CYSRT1, SLC17A9, PSMB5, LGALS9, and TJP2 exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene among CYSRT1, SLC17A9, PSMB5, LGALS9, and TJP2 exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the t follicular helper cell–activated genes in PINNACLE, defining this intersection as the cell-type-specific targets for follicular lymphoma. Compute their average embedding to serve as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GRIPAP1', 'ALG13', 'ETHE1', 'CDK6', 'FDXACB1']",follicular lymphoma,t follicular helper cell,CDK6,"Among the genes GRIPAP1, ALG13, ETHE1, CDK6, and FDXACB1, which one shows the highest cell-type specificity in T follicular helper cells, making it the best candidate for targeting follicular lymphoma?","Among the genes GRIPAP1, ALG13, ETHE1, CDK6, and FDXACB1, which one shows the highest cell-type specificity in T follicular helper cells, making it the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and t follicular helper cell–activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STAG3', 'SGSM1', 'MAD1L1', 'NDUFC1', 'WDR83OS']",follicular lymphoma,t follicular helper cell,NDUFC1,"Which gene among STAG3, SGSM1, MAD1L1, NDUFC1, and WDR83OS exhibits the highest specificity for T follicular helper cells in the context of follicular lymphoma targeting?","Which gene among STAG3, SGSM1, MAD1L1, NDUFC1, and WDR83OS exhibits the highest specificity for T follicular helper cells in the context of follicular lymphoma targeting? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual gene. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['IFNAR1', 'PRDM10', 'BMP4', 'IL16', 'ARPC1B']",follicular lymphoma,t follicular helper cell,IFNAR1,"Among the genes IFNAR1, PRDM10, BMP4, IL16, and ARPC1B, which one shows the highest specificity in T follicular helper cells as the primary candidate for targeted follicular lymphoma therapy?","Among the genes IFNAR1, PRDM10, BMP4, IL16, and ARPC1B, which one shows the highest specificity in T follicular helper cells as the primary candidate for targeted follicular lymphoma therapy? For follicular lymphoma, identify the validated therapeutic targets and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the t follicular helper cell-activated genes within PINNACLE, defining this intersection as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and then calculate the cosine similarity between the average and each individual target. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its relevance in the biology of follicular lymphoma."
"['ZC3H7A', 'OR4F29', 'MT-ND3', 'DNAJC10', 'CSF2RB']",follicular lymphoma,t follicular helper cell,MT-ND3,"Among the genes ZC3H7A, OR4F29, MT-ND3, DNAJC10, and CSF2RB, which one exhibits the highest specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma?","Among the genes ZC3H7A, OR4F29, MT-ND3, DNAJC10, and CSF2RB, which one exhibits the highest specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of t follicular helper cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this average embedding and the embeddings of each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SSX4B', 'IL24', 'XPNPEP1', 'DNMT1', 'HSD17B10']",follicular lymphoma,t follicular helper cell,DNMT1,"Which gene among SSX4B, IL24, XPNPEP1, DNMT1, and HSD17B10 exhibits the highest specificity in T follicular helper cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among SSX4B, IL24, XPNPEP1, DNMT1, and HSD17B10 exhibits the highest specificity in T follicular helper cells, making it the optimal candidate for targeting follicular lymphoma? What are the verified therapeutic targets for follicular lymphoma that overlap with t follicular helper cell–activated genes in the PINNACLE database, and what are their cell-type–specific embeddings? Please compute the average embedding of this overlapping set and determine the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['CREBZF', 'POLD4', 'CASP14', 'IGFBP4', 'CYP11B2']",follicular lymphoma,t follicular helper cell,POLD4,"Among the genes CREBZF, POLD4, CASP14, IGFBP4, and CYP11B2, which one demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Among the genes CREBZF, POLD4, CASP14, IGFBP4, and CYP11B2, which one demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Then, identify which t follicular helper cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GTF2H1', 'CCDC125', 'PRKACG', 'CD38', 'PMM2']",follicular lymphoma,t follicular helper cell,CD38,"Among the following genes—GTF2H1, CCDC125, PRKACG, CD38, and PMM2—which one exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising candidate target for follicular lymphoma?","Among the following genes—GTF2H1, CCDC125, PRKACG, CD38, and PMM2—which one exhibits the highest cell-type specificity in T follicular helper cells, thereby representing the most promising candidate target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set to serve as a reference, and then calculate the cosine similarity between the reference and each individual target embedding. Finally, if one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CLEC4C', 'SARNP', 'NDUFS5', 'HGH1', 'FXYD1']",follicular lymphoma,t follicular helper cell,NDUFS5,"Which gene—CLEC4C, SARNP, NDUFS5, HGH1, or FXYD1—exhibits the highest expression specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene—CLEC4C, SARNP, NDUFS5, HGH1, or FXYD1—exhibits the highest expression specificity in T follicular helper cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, compare these targets with the t follicular helper cell-activated genes in PINNACLE to determine the overlapping gene set. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this average and each gene’s embedding. If one gene shows a substantially higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDC42EP4', 'MAGED4B', 'MATN3', 'IL2RB', 'COL2A1']",follicular lymphoma,t follicular helper cell,IL2RB,"Among the genes CDC42EP4, MAGED4B, MATN3, IL2RB, and COL2A1, which one exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Among the genes CDC42EP4, MAGED4B, MATN3, IL2RB, and COL2A1, which one exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T follicular helper cell-activated genes in PINNACLE overlap with these targets, constituting the cell-type–specific targets for follicular lymphoma. Calculate an average embedding reference vector from this overlapping set, then compute the cosine similarity between this reference and each individual target embedding. If one gene demonstrates significantly higher similarity relative to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ZNF581', 'FKBP1A', 'PMF1-BGLAP', 'NUDCD3', 'PDXDC1']",follicular lymphoma,t follicular helper cell,FKBP1A,"Which gene among ZNF581, FKBP1A, PMF1-BGLAP, NUDCD3, and PDXDC1 shows the most specific expression in T follicular helper cells for targeted intervention in follicular lymphoma?","Which gene among ZNF581, FKBP1A, PMF1-BGLAP, NUDCD3, and PDXDC1 shows the most specific expression in T follicular helper cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the t follicular helper cell–activated genes in PINNACLE to establish a set of cell-type–specific targets. Using this set, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['UQCR10', 'TRAF5', 'FAM228A', 'NAMPT', 'CELF2']",follicular lymphoma,t follicular helper cell,CELF2,"Among the genes UQCR10, TRAF5, FAM228A, NAMPT, and CELF2, which one exhibits the most specific expression in T follicular helper cells, making it the most promising target for follicular lymphoma therapy?","Among the genes UQCR10, TRAF5, FAM228A, NAMPT, and CELF2, which one exhibits the most specific expression in T follicular helper cells, making it the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with t follicular helper cell–activated genes in PINNACLE to create a refined set of cell-type–specific targets. Compute the average embedding for this overlap and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MDM2', 'ARMC7', 'PZP', 'ARHGAP24', 'OTC']",follicular lymphoma,t follicular helper cell,MDM2,"Among the genes MDM2, ARMC7, PZP, ARHGAP24, and OTC, which one exhibits the greatest specificity in T follicular helper cells for targeting follicular lymphoma?","Among the genes MDM2, ARMC7, PZP, ARHGAP24, and OTC, which one exhibits the greatest specificity in T follicular helper cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the t follicular helper cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PREB', 'UBAP2', 'THYN1', 'HDAC3', 'LIN9']",follicular lymphoma,t follicular helper cell,HDAC3,"Which gene among PREB, UBAP2, THYN1, HDAC3, and LIN9 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among PREB, UBAP2, THYN1, HDAC3, and LIN9 exhibits the highest cell-type specificity in T follicular helper cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Given the validated therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from PINNACLE. Identify the subset of T follicular helper cell-activated genes in PINNACLE that overlaps with these targets. Using this overlapping set, compute their average embedding as a reference, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BHLHB9', 'RAD23B', 'TSKS', 'CEBPB', 'MT-ND3']",follicular lymphoma,cd4-positive alpha-beta t cell,MT-ND3,"Among the genes BHLHB9, RAD23B, TSKS, CEBPB, and MT-ND3, which shows the most specific expression in CD4-positive alpha-beta T cells for potential targeting of follicular lymphoma?","Among the genes BHLHB9, RAD23B, TSKS, CEBPB, and MT-ND3, which shows the most specific expression in CD4-positive alpha-beta T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of cd4-positive alpha-beta T cell-activated genes in PINNACLE. Using this overlapping set, compute the average embedding as a reference for follicular lymphoma's cell-type specificity, then calculate the cosine similarity between this reference vector and each individual gene's embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['YJEFN3', 'SUFU', 'NDUFV1', 'ESYT1', 'MRPL34']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFV1,"Which gene among YJEFN3, SUFU, NDUFV1, ESYT1, and MRPL34 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among YJEFN3, SUFU, NDUFV1, ESYT1, and MRPL34 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping gene set and then compute the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB7', 'ZNF223', 'ALDH3A1', 'DPF3', 'BLVRA']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB7,"Among the genes NDUFB7, ZNF223, ALDH3A1, DPF3, and BLVRA, which one displays the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes NDUFB7, ZNF223, ALDH3A1, DPF3, and BLVRA, which one displays the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell‐type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in CD4-positive alpha-beta T cells. Using the overlapping genes, compute an average embedding as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['MDM2', 'USP12P1', 'HBZ', 'FREM1', 'DEXI']",follicular lymphoma,cd4-positive alpha-beta t cell,MDM2,"Which gene among MDM2, USP12P1, HBZ, FREM1, and DEXI demonstrates the highest cell-type specificity in CD4+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among MDM2, USP12P1, HBZ, FREM1, and DEXI demonstrates the highest cell-type specificity in CD4+ alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta T cell–activated genes available in PINNACLE. Calculate the average embedding of this overlapping set (the cell-type–specific targets for follicular lymphoma), then compute the cosine similarity between this reference embedding and each individual target's embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['CDK2', 'NPPC', 'TMPRSS11D', 'COL8A1', 'CDCA7L']",follicular lymphoma,cd4-positive alpha-beta t cell,CDK2,"Among the genes CDK2, NPPC, TMPRSS11D, COL8A1, and CDCA7L, which one exhibits the highest specificity in CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes CDK2, NPPC, TMPRSS11D, COL8A1, and CDCA7L, which one exhibits the highest specificity in CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the CD4-positive, αβ T cell-activated genes available in PINNACLE; this shared set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping targets, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADAMTSL5', 'TPSG1', 'NDUFS2', 'KCNE4', 'CABYR']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFS2,"Which gene—ADAMTSL5, TPSG1, NDUFS2, KCNE4, or CABYR—exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells as a target for follicular lymphoma?","Which gene—ADAMTSL5, TPSG1, NDUFS2, KCNE4, or CABYR—exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells as a target for follicular lymphoma? Retrieve the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Identify the intersection between these targets and the CD4-positive αβ T cell–activated genes in PINNACLE, defining this overlap as the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping targets, then determine the cosine similarity between this reference and each individual target. If one gene displays a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARG1', 'NCLN', 'RAI1', 'AURKA', 'KLC2']",follicular lymphoma,cd4-positive alpha-beta t cell,AURKA,"Which gene among ARG1, NCLN, RAI1, AURKA, and KLC2 demonstrates the highest specificity in CD4-positive αβ T cells as a potential molecular target for follicular lymphoma?","Which gene among ARG1, NCLN, RAI1, AURKA, and KLC2 demonstrates the highest specificity in CD4-positive αβ T cells as a potential molecular target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, find the overlap between these targets and PINNACLE’s CD4-positive alpha-beta T cell-activated genes to establish the cell-type-specific targets for follicular lymphoma. Calculate the average embedding of these overlapping genes, then compute the cosine similarity between this average embedding and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and justify its biological relevance with concise evidence."
"['HOXB6', 'RUFY4', 'F13B', 'NDUFB1', 'ICMT']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB1,"Which gene among HOXB6, RUFY4, F13B, NDUFB1, and ICMT shows the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma?","Which gene among HOXB6, RUFY4, F13B, NDUFB1, and ICMT shows the highest cell-type specificity in CD4-positive αβ T cells for targeting follicular lymphoma? For follicular lymphoma, retrieve the verified therapeutic targets and their corresponding cell-type–specific embeddings from PINNACLE. Next, identify which of these targets overlap with the set of CD4-positive alpha-beta T cell–activated genes available in PINNACLE to form a panel of cell-type–specific targets. Compute the average embedding of this overlapping set and then assess the cosine similarity between each individual target’s embedding and this average. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CTSA', 'CYBRD1', 'ZBTB34', 'RARS2', 'TNFRSF4']",follicular lymphoma,cd4-positive alpha-beta t cell,TNFRSF4,"Among the candidate genes CTSA, CYBRD1, ZBTB34, RARS2, and TNFRSF4, which exhibits the highest cell-type specificity in CD4+ αβ T cells and is therefore the most promising target for follicular lymphoma?","Among the candidate genes CTSA, CYBRD1, ZBTB34, RARS2, and TNFRSF4, which exhibits the highest cell-type specificity in CD4+ αβ T cells and is therefore the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell activated gene set in PINNACLE. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ITIH3', 'BCL6', 'PCDHA5', 'BDKRB1', 'CDK4']",follicular lymphoma,cd4-positive alpha-beta t cell,CDK4,"Among the genes ITIH3, BCL6, PCDHA5, BDKRB1, and CDK4, which one exhibits the highest specificity in CD4+ alpha-beta T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among the genes ITIH3, BCL6, PCDHA5, BDKRB1, and CDK4, which one exhibits the highest specificity in CD4+ alpha-beta T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the cd4-positive alpha-beta T cell-activated genes available in PINNACLE, thereby defining the relevant cell-type–specific target set. Compute the average embedding of this overlapping set to serve as a reference, and then assess the cosine similarity between this reference and each individual target. If one gene exhibits a notably higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological significance."
"['LMAN2L', 'LRFN4', 'POLD3', 'FGF8', 'NAPRT']",follicular lymphoma,cd4-positive alpha-beta t cell,POLD3,"Among LMAN2L, LRFN4, POLD3, FGF8, and NAPRT, which gene shows the highest cell-type specificity in CD4-positive αβ T cells, making it the most suitable candidate for targeting follicular lymphoma?","Among LMAN2L, LRFN4, POLD3, FGF8, and NAPRT, which gene shows the highest cell-type specificity in CD4-positive αβ T cells, making it the most suitable candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta T cell-activated genes present in PINNACLE, designating this intersection as the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this gene set and compute the cosine similarity between this reference and each individual target embedding. If a single gene shows a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AGPAT4', 'RFTN1', 'ABHD16A', 'ZNF747', 'MT-ND4']",follicular lymphoma,cd4-positive alpha-beta t cell,MT-ND4,"Which gene among AGPAT4, RFTN1, ABHD16A, ZNF747, and MT-ND4 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among AGPAT4, RFTN1, ABHD16A, ZNF747, and MT-ND4 exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4+ alpha-beta T cell activation genes in PINNACLE to define the cell-type-specific targets. Compute the average embedding for these overlapping targets and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SIGLEC9', 'FKBP10', 'NDUFAB1', 'KCNMA1', 'REXO2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFAB1,"Which gene—SIGLEC9, FKBP10, NDUFAB1, KCNMA1, or REXO2—demonstrates the highest specificity for CD4+ αβ T cells, making it the most promising target for follicular lymphoma intervention?","Which gene—SIGLEC9, FKBP10, NDUFAB1, KCNMA1, or REXO2—demonstrates the highest specificity for CD4+ αβ T cells, making it the most promising target for follicular lymphoma intervention? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell–activated genes recorded in PINNACLE, defining this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these targets as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene consistently shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MED12L', 'NDUFS5', 'ADSS2', 'ACBD7', 'SLC2A2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFS5,"Among the genes MED12L, NDUFS5, ADSS2, ACBD7, and SLC2A2, which one exhibits the highest cell-type specificity for CD4+ αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes MED12L, NDUFS5, ADSS2, ACBD7, and SLC2A2, which one exhibits the highest cell-type specificity for CD4+ αβ T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell‐type–specific embeddings from the PINNACLE database. Next, determine which of the cd4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PCDHA1', 'KRTAP10-10', 'PSMB5', 'ARL6', 'SPATA4']",follicular lymphoma,cd4-positive alpha-beta t cell,PSMB5,"Which gene among PCDHA1, KRTAP10-10, PSMB5, ARL6, and SPATA4 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma?","Which gene among PCDHA1, KRTAP10-10, PSMB5, ARL6, and SPATA4 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma using PINNACLE and retrieve their cell-type-specific embeddings. Next, determine which of these targets overlap with genes activated in CD4-positive alpha-beta T cells as recorded in PINNACLE. Calculate the average embedding of this overlapping gene set, and then compute the cosine similarity between this average reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RUFY3', 'FOLR3', 'SLC36A1', 'NDUFB4', 'ABCB11']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB4,"Which of the following genes—RUFY3, FOLR3, SLC36A1, NDUFB4, or ABCB11—exhibits the highest cell-type specificity in CD4+ αβ T cells for targeting follicular lymphoma?","Which of the following genes—RUFY3, FOLR3, SLC36A1, NDUFB4, or ABCB11—exhibits the highest cell-type specificity in CD4+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of cd4-positive alpha-beta T cell–activated genes available in PINNACLE. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['PLOD1', 'POLD2', 'RAD51AP1', 'IFNL2', 'HLA-B']",follicular lymphoma,cd4-positive alpha-beta t cell,POLD2,"Which gene among PLOD1, POLD2, RAD51AP1, IFNL2, and HLA-B exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma?","Which gene among PLOD1, POLD2, RAD51AP1, IFNL2, and HLA-B exhibits the highest specificity in CD4-positive alpha-beta T cells, making it the most promising target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes associated with CD4-positive alpha–beta T cell activation in PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and the individual embeddings of each target gene. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CNOT4', 'TVP23B', 'NDUFA9', 'HSD17B7', 'CR2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFA9,"Among the candidate genes CNOT4, TVP23B, NDUFA9, HSD17B7, and CR2, which demonstrates the highest cell-type specificity in CD4-positive αβ T cells as the most suitable target for follicular lymphoma therapy?","Among the candidate genes CNOT4, TVP23B, NDUFA9, HSD17B7, and CR2, which demonstrates the highest cell-type specificity in CD4-positive αβ T cells as the most suitable target for follicular lymphoma therapy? Determine the verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, identify which of these targets overlap with the set of CD4-positive alpha-beta T cell-activated genes in PINNACLE. These overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these targets and then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['DESI1', 'MASTL', 'ACTN4', 'ARHGAP10', 'DNMT3A']",follicular lymphoma,cd4-positive alpha-beta t cell,DNMT3A,"Among the genes DESI1, MASTL, ACTN4, ARHGAP10, and DNMT3A, which exhibits the highest specificity in CD4-positive αβ T cells for targeted treatment of follicular lymphoma?","Among the genes DESI1, MASTL, ACTN4, ARHGAP10, and DNMT3A, which exhibits the highest specificity in CD4-positive αβ T cells for targeted treatment of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of the CD4-positive alpha-beta T cell activation genes in PINNACLE overlap with these targets to obtain the cell-type-specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference vector and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDP', 'POLD4', 'CREG1', 'TRHR', 'NLRP2']",follicular lymphoma,cd4-positive alpha-beta t cell,POLD4,"Which gene among NDP, POLD4, CREG1, TRHR, and NLRP2 exhibits the highest cell-type specificity in CD4+ αβ T cells relevant to targeting follicular lymphoma?","Which gene among NDP, POLD4, CREG1, TRHR, and NLRP2 exhibits the highest cell-type specificity in CD4+ αβ T cells relevant to targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma by retrieving their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the CD4-positive alpha-beta T cell–activated genes available in PINNACLE. Compute the mean embedding for this overlapping set, then calculate the cosine similarity between the mean embedding and each individual target’s embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['IFNAR1', 'NPNT', 'DCUN1D4', 'PCNA', 'DPF2']",follicular lymphoma,regulatory t cell,IFNAR1,"Among the genes IFNAR1, NPNT, DCUN1D4, PCNA, and DPF2, which exhibits the highest cell-type specificity in regulatory T cells, making it the best candidate for targeting follicular lymphoma?","Among the genes IFNAR1, NPNT, DCUN1D4, PCNA, and DPF2, which exhibits the highest cell-type specificity in regulatory T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma that have corresponding cell-type–specific embeddings in PINNACLE. Next, determine which of these targets overlap with the regulatory T cell–activated genes listed in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target's embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['CDK4', 'GPNMB', 'ZNF318', 'NRG3', 'SLC23A2']",follicular lymphoma,regulatory t cell,CDK4,"Which gene among CDK4, GPNMB, ZNF318, NRG3, and SLC23A2 exhibits the greatest cell-type specificity within regulatory T cells for targeting follicular lymphoma?","Which gene among CDK4, GPNMB, ZNF318, NRG3, and SLC23A2 exhibits the greatest cell-type specificity within regulatory T cells for targeting follicular lymphoma? Identify confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of regulatory T cell-activated genes from PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CYP2C8', 'NDUFAF4', 'OXA1L', 'COPZ1', 'POMT2']",follicular lymphoma,regulatory t cell,NDUFAF4,"Among the genes CYP2C8, NDUFAF4, OXA1L, COPZ1, and POMT2, which shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes CYP2C8, NDUFAF4, OXA1L, COPZ1, and POMT2, which shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the regulatory T cell–activated genes in PINNACLE, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this gene set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TIGD7', 'MCL1', 'UBTD2', 'HOXB1', 'FUT1']",follicular lymphoma,regulatory t cell,MCL1,"Among TIGD7, MCL1, UBTD2, HOXB1, and FUT1, which gene demonstrates the most specific expression in regulatory T cells, making it the optimal candidate for targeting follicular lymphoma?","Among TIGD7, MCL1, UBTD2, HOXB1, and FUT1, which gene demonstrates the most specific expression in regulatory T cells, making it the optimal candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the regulatory T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this intersecting set, then compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TUBB', 'RGS14', 'PAQR5', 'SNAPIN', 'KCNC2']",follicular lymphoma,regulatory t cell,TUBB,"Which gene among TUBB, RGS14, PAQR5, SNAPIN, and KCNC2 exhibits the highest regulatory T cell-specific expression relevant for targeting follicular lymphoma?","Which gene among TUBB, RGS14, PAQR5, SNAPIN, and KCNC2 exhibits the highest regulatory T cell-specific expression relevant for targeting follicular lymphoma? Which validated therapeutic targets for follicular lymphoma can be identified based on their cell-type–specific embeddings in PINNACLE? From these, which regulatory T cell–activated genes overlap to form the set of cell-type–specific targets? For this overlapping set, compute the average embedding to serve as a reference, and then determine the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DACT3', 'ZCCHC8', 'HLA-DRB5', 'ZNF233', 'HDGFL3']",follicular lymphoma,regulatory t cell,HLA-DRB5,"Among the genes DACT3, ZCCHC8, HLA-DRB5, ZNF233, and HDGFL3, which one shows the highest cell-type specificity in regulatory T cells used for targeting follicular lymphoma?","Among the genes DACT3, ZCCHC8, HLA-DRB5, ZNF233, and HDGFL3, which one shows the highest cell-type specificity in regulatory T cells used for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which regulatory T cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding for these overlapping genes to serve as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. Nominate the gene with a clearly higher similarity as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IWS1', 'PYGO2', 'TNFRSF4', 'AMY2B', 'FBXL14']",follicular lymphoma,regulatory t cell,TNFRSF4,"Among the candidate genes IWS1, PYGO2, TNFRSF4, AMY2B, and FBXL14, which exhibits the most cell type–specific expression in regulatory T cells, thereby representing the best potential target for follicular lymphoma therapy?","Among the candidate genes IWS1, PYGO2, TNFRSF4, AMY2B, and FBXL14, which exhibits the most cell type–specific expression in regulatory T cells, thereby representing the best potential target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific gene embeddings from PINNACLE. Next, determine which of these targets overlap with the regulatory T cell–activated genes in PINNACLE to generate a candidate set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA8', 'MAD2L2', 'KLHL21', 'LMO2', 'RPS27L']",follicular lymphoma,regulatory t cell,NDUFA8,"Among the genes NDUFA8, MAD2L2, KLHL21, LMO2, and RPS27L, which one exhibits the highest cell-type-specific expression in regulatory T cells relevant to targeting follicular lymphoma?","Among the genes NDUFA8, MAD2L2, KLHL21, LMO2, and RPS27L, which one exhibits the highest cell-type-specific expression in regulatory T cells relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. From the regulatory T cell activation-associated genes in PINNACLE, determine the subset that overlaps with these targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['ANAPC11', 'NDUFA7', 'PLEKHN1', 'LRRC8E', 'ERMN']",follicular lymphoma,regulatory t cell,NDUFA7,"Which gene among ANAPC11, NDUFA7, PLEKHN1, LRRC8E, and ERMN demonstrates the highest specificity in regulatory T cells for targeting follicular lymphoma?","Which gene among ANAPC11, NDUFA7, PLEKHN1, LRRC8E, and ERMN demonstrates the highest specificity in regulatory T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell type-specific embeddings from PINNACLE. Next, determine which PINNACLE regulatory T cell-activated genes overlap with these targets to define the cell type-specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['FRMD4A', 'CDH1', 'CDAN1', 'PIK3R1', 'C9orf78']",follicular lymphoma,regulatory t cell,PIK3R1,"Among the genes FRMD4A, CDH1, CDAN1, PIK3R1, and C9orf78, which one demonstrates the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes FRMD4A, CDH1, CDAN1, PIK3R1, and C9orf78, which one demonstrates the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the set of verified therapeutic targets for follicular lymphoma and retrieve their cell-type‐specific embeddings from PINNACLE. Next, determine which regulatory T cell–activated genes from PINNACLE overlap with this target set, and compute the average embedding for these overlapping genes as a reference. Finally, calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C1D', 'NDUFS5', 'TRIML2', 'ING3', 'POU2AF1']",follicular lymphoma,regulatory t cell,NDUFS5,"Among the candidate genes C1D, NDUFS5, TRIML2, ING3, and POU2AF1, which one shows the highest cell-type specificity in regulatory T cells relevant to follicular lymphoma?","Among the candidate genes C1D, NDUFS5, TRIML2, ING3, and POU2AF1, which one shows the highest cell-type specificity in regulatory T cells relevant to follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the regulatory T cell–activated genes in PINNACLE to obtain an overlapping set. Calculate the average embedding of this overlap and then determine the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IMPDH2', 'IGFBP1', 'EIF3A', 'H4C15', 'ROPN1']",follicular lymphoma,regulatory t cell,IMPDH2,"Which gene among IMPDH2, IGFBP1, EIF3A, H4C15, and ROPN1 exhibits the highest specificity for regulatory T cells in the context of targeting follicular lymphoma?","Which gene among IMPDH2, IGFBP1, EIF3A, H4C15, and ROPN1 exhibits the highest specificity for regulatory T cells in the context of targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell type–specific embeddings from the PINNACLE database. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets to create a set of cell type–specific targets for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CMTM2', 'SIGLECL1', 'HLA-DRB1', 'CPSF4', 'TMEM30B']",follicular lymphoma,regulatory t cell,HLA-DRB1,"Among the candidate genes CMTM2, SIGLECL1, HLA-DRB1, CPSF4, and TMEM30B, which one demonstrates the greatest expression specificity in regulatory T cells for potential targeted therapy in follicular lymphoma?","Among the candidate genes CMTM2, SIGLECL1, HLA-DRB1, CPSF4, and TMEM30B, which one demonstrates the greatest expression specificity in regulatory T cells for potential targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of the regulatory T cell-activated genes in PINNACLE overlap with these targets. For this overlapping gene set, compute the average embedding as a reference and calculate the cosine similarity between the reference and each individual gene embedding. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GLI1', 'MT-ND2', 'NUDT4', 'RHBG', 'CGAS']",follicular lymphoma,regulatory t cell,MT-ND2,"Among GLI1, MT-ND2, NUDT4, RHBG, and CGAS, which gene shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among GLI1, MT-ND2, NUDT4, RHBG, and CGAS, which gene shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma with cell-type–specific embeddings in PINNACLE and determine which of these overlap with regulatory T cell-activated genes in the dataset. Using this overlapping set as the cell-type–specific targets, compute their average embedding as a reference. Then, calculate the cosine similarity between the reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['AIM2', 'MIER3', 'NR3C1', 'TMEM59', 'FOXRED2']",follicular lymphoma,regulatory t cell,NR3C1,"Which gene among AIM2, MIER3, NR3C1, TMEM59, and FOXRED2 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Which gene among AIM2, MIER3, NR3C1, TMEM59, and FOXRED2 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in regulatory T cells from PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set as a reference, then calculate the cosine similarity between the reference and each target embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['UBE2V2', 'PSMB5', 'ARMC7', 'WRAP73', 'KIAA0753']",follicular lymphoma,regulatory t cell,PSMB5,"Which gene among UBE2V2, PSMB5, ARMC7, WRAP73, and KIAA0753 demonstrates the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among UBE2V2, PSMB5, ARMC7, WRAP73, and KIAA0753 demonstrates the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell type–specific embeddings from the PINNACLE database. Next, find the overlap between these targets and the regulatory T cell–activated genes in PINNACLE to establish a subset of cell type–specific follicular lymphoma targets. Calculate the average embedding for this subset and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBM14', 'NDUFA11', 'TRIM55', 'CD200', 'SERF1A']",follicular lymphoma,regulatory t cell,NDUFA11,"Among the genes RBM14, NDUFA11, TRIM55, CD200, and SERF1A, which exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes RBM14, NDUFA11, TRIM55, CD200, and SERF1A, which exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T cell–activated genes from PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and each individual target. Finally, if one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PSMC5', 'JAK3', 'WASF3', 'IQCF3', 'PLRG1']",follicular lymphoma,regulatory t cell,JAK3,"Among the genes PSMC5, JAK3, WASF3, IQCF3, and PLRG1, which one exhibits the most cell-type-specific expression in regulatory T cells, making it a prime candidate for targeting follicular lymphoma?","Among the genes PSMC5, JAK3, WASF3, IQCF3, and PLRG1, which one exhibits the most cell-type-specific expression in regulatory T cells, making it a prime candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the regulatory T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between the reference embedding and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SRD5A1', 'APOD', 'IL18R1', 'KIF9', 'MT-ND6']",follicular lymphoma,regulatory t cell,MT-ND6,"Which gene among SRD5A1, APOD, IL18R1, KIF9, and MT-ND6 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Which gene among SRD5A1, APOD, IL18R1, KIF9, and MT-ND6 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which targets overlap with regulatory T cell–activated genes in PINNACLE, and compute the average embedding of this overlapping set. Finally, calculate the cosine similarity between this reference embedding and each individual target’s embedding; if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['CASP3', 'RAB7B', 'MT-ND3', 'GGT6', 'PPBP']",follicular lymphoma,regulatory t cell,MT-ND3,"Which gene among CASP3, RAB7B, MT‐ND3, GGT6, and PPBP exhibits the highest specificity in regulatory T cells for targeting follicular lymphoma?","Which gene among CASP3, RAB7B, MT‐ND3, GGT6, and PPBP exhibits the highest specificity in regulatory T cells for targeting follicular lymphoma? Identify the experimentally validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in regulatory T cells in PINNACLE—this overlapping set defines the candidate cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this set, compute the cosine similarity between this average embedding and each individual target's embedding, and nominate the gene with a significantly higher similarity as the top candidate, providing a concise evidence-based justification for its biological relevance."
"['C1RL', 'LCK', 'EFEMP1', 'DGKD', 'RRP12']",follicular lymphoma,exhausted t cell,LCK,"Which gene among C1RL, LCK, EFEMP1, DGKD, and RRP12 exhibits the highest specificity in exhausted T cells for targeting follicular lymphoma?","Which gene among C1RL, LCK, EFEMP1, DGKD, and RRP12 exhibits the highest specificity in exhausted T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell–activated genes in PINNACLE overlap with these targets to define the set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based explanation of its biological relevance."
"['NKX2-2', 'PTGIR', 'HTATSF1', 'NDUFC2', 'IKBKE']",follicular lymphoma,exhausted t cell,NDUFC2,"Among the candidate genes (NKX2-2, PTGIR, HTATSF1, NDUFC2, and IKBKE), which exhibits the highest specificity for exhausted T cells, suggesting its potential as the most promising target for follicular lymphoma therapy?","Among the candidate genes (NKX2-2, PTGIR, HTATSF1, NDUFC2, and IKBKE), which exhibits the highest specificity for exhausted T cells, suggesting its potential as the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the exhausted T cell–activated genes in PINNACLE, defining a refined candidate set. Compute the average embedding of this candidate set as a reference and calculate the cosine similarity between this reference and the embedding of each candidate target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FGR', 'TAS2R5', 'PLCXD3', 'P2RX6', 'HOXA13']",follicular lymphoma,exhausted t cell,FGR,"Which gene among FGR, TAS2R5, PLCXD3, P2RX6, and HOXA13 exhibits the highest specificity for exhausted T cells, thereby representing the most promising therapeutic target for follicular lymphoma?","Which gene among FGR, TAS2R5, PLCXD3, P2RX6, and HOXA13 exhibits the highest specificity for exhausted T cells, thereby representing the most promising therapeutic target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, isolate those targets that overlap with the set of exhausted T cell–activated genes in PINNACLE, thereby establishing a list of follicular lymphoma cell-type–specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between the average and each individual target's embedding. If a single gene shows a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SMN2', 'SLC12A8', 'NDUFB3', 'SYNE1', 'CYP2F1']",follicular lymphoma,exhausted t cell,NDUFB3,"Among the genes SMN2, SLC12A8, NDUFB3, SYNE1, and CYP2F1, which one exhibits the highest specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma?","Among the genes SMN2, SLC12A8, NDUFB3, SYNE1, and CYP2F1, which one exhibits the highest specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma using cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the exhausted T cell-activated genes in PINNACLE to define the relevant target set. Calculate the average embedding for this set and compute the cosine similarity between this average and each individual target gene's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MRPL30', 'NDUFB5', 'KCNK7', 'CPLX3', 'ZBTB18']",follicular lymphoma,exhausted t cell,NDUFB5,"Among the genes MRPL30, NDUFB5, KCNK7, CPLX3, and ZBTB18, which one exhibits the highest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy?","Among the genes MRPL30, NDUFB5, KCNK7, CPLX3, and ZBTB18, which one exhibits the highest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which genes associated with exhausted, activated T cells in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes to serve as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF711', 'TRAPPC2', 'NDUFS6', 'TMEM256-PLSCR3', 'MSS51']",follicular lymphoma,exhausted t cell,NDUFS6,"Among the following genes—ZNF711, TRAPPC2, NDUFS6, TMEM256-PLSCR3, and MSS51—which one exhibits the highest specificity for exhausted T cells as a target for follicular lymphoma treatment?","Among the following genes—ZNF711, TRAPPC2, NDUFS6, TMEM256-PLSCR3, and MSS51—which one exhibits the highest specificity for exhausted T cells as a target for follicular lymphoma treatment? Identify the validated therapeutic targets for follicular lymphoma that have cell-type–specific embeddings in PINNACLE. From these, determine the subset that overlaps with PINNACLE's exhausted T cell-activated genes, thereby establishing follicular lymphoma–specific targets. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AADAT', 'KDM1A', 'MT-ND4L', 'MIB1', 'SLC2A8']",follicular lymphoma,exhausted t cell,MT-ND4L,"Which gene among AADAT, KDM1A, MT-ND4L, MIB1, and SLC2A8 exhibits the greatest cell-type-specific expression in exhausted T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among AADAT, KDM1A, MT-ND4L, MIB1, and SLC2A8 exhibits the greatest cell-type-specific expression in exhausted T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in exhausted T cells listed in PINNACLE. Compute the average embedding of this overlapping set to create a reference profile, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPR143', 'PDCD1', 'FAIM2', 'SPATS1', 'USP34']",follicular lymphoma,exhausted t cell,PDCD1,"Which gene among GPR143, PDCD1, FAIM2, SPATS1, and USP34 exhibits the highest specificity in exhausted T cells, making it the most promising target for therapeutic intervention in follicular lymphoma?","Which gene among GPR143, PDCD1, FAIM2, SPATS1, and USP34 exhibits the highest specificity in exhausted T cells, making it the most promising target for therapeutic intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the exhausted T cell–activated genes from PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLX1B', 'NDUFA5', 'PDLIM1', 'PC', 'WDR33']",follicular lymphoma,exhausted t cell,NDUFA5,"Among the genes SLX1B, NDUFA5, PDLIM1, PC, and WDR33, which one exhibits the highest cell-type specificity in exhausted T cells relevant to targeting follicular lymphoma?","Among the genes SLX1B, NDUFA5, PDLIM1, PC, and WDR33, which one exhibits the highest cell-type specificity in exhausted T cells relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes associated with exhausted T cell activation in PINNACLE. For the overlapping gene set, compute the average embedding and measure the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFA12', 'C1QTNF5', 'PEX1', 'OBP2A', 'RPP14']",follicular lymphoma,exhausted t cell,NDUFA12,"Which gene among NDUFA12, C1QTNF5, PEX1, OBP2A, and RPP14 exhibits the highest cell-type specificity in exhausted T cells, thereby serving as the most promising single candidate for targeted therapy in follicular lymphoma?","Which gene among NDUFA12, C1QTNF5, PEX1, OBP2A, and RPP14 exhibits the highest cell-type specificity in exhausted T cells, thereby serving as the most promising single candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in exhausted T cells overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RPS13', 'NDUFB9', 'SYT6', 'ISM2', 'NUDT3']",follicular lymphoma,exhausted t cell,NDUFB9,"Among RPS13, NDUFB9, SYT6, ISM2, and NUDT3, which gene exhibits the highest specificity in exhausted T cells, making it the most promising candidate target for follicular lymphoma?","Among RPS13, NDUFB9, SYT6, ISM2, and NUDT3, which gene exhibits the highest specificity in exhausted T cells, making it the most promising candidate target for follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the exhausted T cell–activated genes available in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation of its biological significance."
"['DEFB121', 'PHF20L1', 'FAM120B', 'ZNF236', 'PRKCB']",follicular lymphoma,exhausted t cell,PRKCB,"Which gene—DEFB121, PHF20L1, FAM120B, ZNF236, or PRKCB—demonstrates the highest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy?","Which gene—DEFB121, PHF20L1, FAM120B, ZNF236, or PRKCB—demonstrates the highest cell-type specificity in exhausted T cells, making it the most promising target for follicular lymphoma therapy? Identify experimentally validated therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Then, find the intersection between these targets and the exhausted T cell–activated gene set from PINNACLE, representing the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set to serve as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma treatment."
"['SRA1', 'VMAC', 'AVEN', 'NUDT5', 'NDUFA8']",follicular lymphoma,exhausted t cell,NDUFA8,"Among SRA1, VMAC, AVEN, NUDT5, and NDUFA8, which gene exhibits the greatest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Among SRA1, VMAC, AVEN, NUDT5, and NDUFA8, which gene exhibits the greatest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which exhausted T cell-activated genes within PINNACLE overlap with these targets to form a set of cell-type–specific targets. Compute the average embedding of this set as a reference and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ISLR2', 'PRKAR1A', 'ACAT1', 'NDUFS3', 'SYNJ2BP']",follicular lymphoma,exhausted t cell,NDUFS3,"Among ISLR2, PRKAR1A, ACAT1, NDUFS3, and SYNJ2BP—which gene exhibits the highest specificity for exhausted T cells, making it the most promising target for follicular lymphoma?","Among ISLR2, PRKAR1A, ACAT1, NDUFS3, and SYNJ2BP—which gene exhibits the highest specificity for exhausted T cells, making it the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of exhausted T cell–activated genes in PINNACLE to define a follicular lymphoma‐specific gene subset. Calculate the average embedding for this subset as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NTN1', 'NSG1', 'POLD4', 'CDKL3', 'ADORA1']",follicular lymphoma,exhausted t cell,POLD4,"Among the candidate genes (NTN1, NSG1, POLD4, CDKL3, ADORA1), which one exhibits the highest cell-type specificity in exhausted T cells, thereby representing the best target for follicular lymphoma therapy?","Among the candidate genes (NTN1, NSG1, POLD4, CDKL3, ADORA1), which one exhibits the highest cell-type specificity in exhausted T cells, thereby representing the best target for follicular lymphoma therapy? Retrieve the verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Identify the targets that overlap with the exhausted T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Next, compute the average embedding of these overlapping genes to establish a reference, and calculate the cosine similarity between this reference and the individual target embeddings. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSMB5', 'HBE1', 'MPP6', 'CYP2D6', 'NOMO3']",follicular lymphoma,exhausted t cell,PSMB5,"Which gene among PSMB5, HBE1, MPP6, CYP2D6, and NOMO3 exhibits the highest specificity in exhausted T cells for targeted intervention in follicular lymphoma?","Which gene among PSMB5, HBE1, MPP6, CYP2D6, and NOMO3 exhibits the highest specificity in exhausted T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the exhausted T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping genes and determine the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity relative to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ALDH4A1', 'MARK4', 'CDK4', 'SECTM1', 'WDR1']",follicular lymphoma,exhausted t cell,CDK4,"Which gene among ALDH4A1, MARK4, CDK4, SECTM1, and WDR1 exhibits the highest specificity in exhausted T cells, making it the most promising target for follicular lymphoma treatment?","Which gene among ALDH4A1, MARK4, CDK4, SECTM1, and WDR1 exhibits the highest specificity in exhausted T cells, making it the most promising target for follicular lymphoma treatment? Identify the verified therapeutic targets for follicular lymphoma using PINNACLE and extract their cell-type–specific embeddings. Then, determine the intersection with genes characteristic of activated, yet exhausted T cells in the PINNACLE dataset. Compute the average embedding of this overlapping set and assess the cosine similarity between this average embedding and that of each individual target. If one gene exhibits a substantially higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POU3F1', 'TLK1', 'METAP2', 'MLXIPL', 'NDUFS2']",follicular lymphoma,exhausted t cell,NDUFS2,"Among the genes POU3F1, TLK1, METAP2, MLXIPL, and NDUFS2, which one exhibits the greatest cell-type specificity in exhausted T cells and represents the most promising target for follicular lymphoma therapy?","Among the genes POU3F1, TLK1, METAP2, MLXIPL, and NDUFS2, which one exhibits the greatest cell-type specificity in exhausted T cells and represents the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the exhausted T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TTC5', 'NDUFA10', 'USP13', 'REPS1', 'PRR20B']",follicular lymphoma,exhausted t cell,NDUFA10,"Among the genes TTC5, NDUFA10, USP13, REPS1, and PRR20B, which exhibits the highest cell-type specificity in exhausted T cells for targeted therapy against follicular lymphoma?","Among the genes TTC5, NDUFA10, USP13, REPS1, and PRR20B, which exhibits the highest cell-type specificity in exhausted T cells for targeted therapy against follicular lymphoma? Using the verified therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Identify the intersection between these targets and the exhausted T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Next, compute the average embedding of these overlapping genes as a reference profile and calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HNRNPH2', 'MAP4', 'PPP3CA', 'VSTM4', 'NDUFS7']",follicular lymphoma,exhausted t cell,NDUFS7,"Which gene among HNRNPH2, MAP4, PPP3CA, VSTM4, and NDUFS7 exhibits the most cell-type specific expression in exhausted T cells, making it the best candidate for targeting follicular lymphoma?","Which gene among HNRNPH2, MAP4, PPP3CA, VSTM4, and NDUFS7 exhibits the most cell-type specific expression in exhausted T cells, making it the best candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma using PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which genes among the exhausted T cell–activated set in PINNACLE overlap with these targets. For the overlapping targets, compute the average embedding and then calculate the cosine similarity between this average and each individual target's embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CELSR2', 'HDAC7', 'HBA1', 'TYR', 'TWSG1']",follicular lymphoma,t cell,HDAC7,"Which gene among CELSR2, HDAC7, HBA1, TYR, and TWSG1 exhibits the highest cell-type specificity in T cells for targeting follicular lymphoma?","Which gene among CELSR2, HDAC7, HBA1, TYR, and TWSG1 exhibits the highest cell-type specificity in T cells for targeting follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the T cell–activated gene set in PINNACLE. For the overlapping targets, compute an average embedding as a reference vector, and then calculate the cosine similarity between this reference and each target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in follicular lymphoma."
"['WDR92', 'ZNF131', 'WWP1', 'NDUFC2', 'CCNA2']",follicular lymphoma,t cell,NDUFC2,"Which gene among WDR92, ZNF131, WWP1, NDUFC2, and CCNA2 exhibits the highest T cell-specific expression for potential application in follicular lymphoma targeting?","Which gene among WDR92, ZNF131, WWP1, NDUFC2, and CCNA2 exhibits the highest T cell-specific expression for potential application in follicular lymphoma targeting? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the subset of these targets that overlap with the T cell-activated genes in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Compute the average embedding for this subset as a reference vector, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'FAM133A', 'COX8C', 'CLPTM1L', 'FFAR1']",follicular lymphoma,t cell,NDUFS5,"Among the genes NDUFS5, FAM133A, COX8C, CLPTM1L, and FFAR1, which one shows the highest T-cell specificity that could make it a promising target for follicular lymphoma therapy?","Among the genes NDUFS5, FAM133A, COX8C, CLPTM1L, and FFAR1, which one shows the highest T-cell specificity that could make it a promising target for follicular lymphoma therapy? Identify the experimentally validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, identify the overlapping genes between these targets and the T cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNMT1', 'URM1', 'MYO15A', 'CDCP1', 'NOL4L']",follicular lymphoma,t cell,DNMT1,"Among the genes DNMT1, URM1, MYO15A, CDCP1, and NOL4L, which one exhibits the highest T-cell specificity and represents the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes DNMT1, URM1, MYO15A, CDCP1, and NOL4L, which one exhibits the highest T-cell specificity and represents the most promising candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with the set of T cell–activated genes in PINNACLE. For this overlapping group, compute the average embedding as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AGTR2', 'HDAC10', 'GJA8', 'DHODH', 'SCARB2']",follicular lymphoma,t cell,HDAC10,"Among AGTR2, HDAC10, GJA8, DHODH, and SCARB2, which gene exhibits the highest specificity of expression in T cells, making it the most promising candidate for targeting in follicular lymphoma?","Among AGTR2, HDAC10, GJA8, DHODH, and SCARB2, which gene exhibits the highest specificity of expression in T cells, making it the most promising candidate for targeting in follicular lymphoma? Using the PINNACLE database, identify verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings. Next, determine which of these targets overlap with the set of T cell-activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding of the overlapping set as a reference, then compute the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['GAGE12F', 'MAP3K3', 'NDUFB3', 'PSPH', 'GNA11']",follicular lymphoma,t cell,NDUFB3,"Which gene among GAGE12F, MAP3K3, NDUFB3, PSPH, and GNA11 exhibits the highest T cell-specific expression, making it the most promising single candidate for targeted follicular lymphoma therapy?","Which gene among GAGE12F, MAP3K3, NDUFB3, PSPH, and GNA11 exhibits the highest T cell-specific expression, making it the most promising single candidate for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s T cell–activated gene set. Compute the average embedding of this overlapping group as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KHDC1', 'FNDC3B', 'SEMA3B', 'HDAC9', 'VSIG1']",follicular lymphoma,t cell,HDAC9,"Among the genes KHDC1, FNDC3B, SEMA3B, HDAC9, and VSIG1, which one exhibits the highest T cell-specific expression relevant for targeting follicular lymphoma?","Among the genes KHDC1, FNDC3B, SEMA3B, HDAC9, and VSIG1, which one exhibits the highest T cell-specific expression relevant for targeting follicular lymphoma? Identify the therapeutic targets for follicular lymphoma that have been validated and extract their cell-type–specific embeddings from PINNACLE. Next, determine which T cell-activated genes from PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation of its biological significance."
"['DYNLT4', 'MDM2', 'SUMO1P1', 'ITGA4', 'SRA1']",follicular lymphoma,t cell,MDM2,"Among the genes DYNLT4, MDM2, SUMO1P1, ITGA4, and SRA1, which shows the most T-cell–specific expression in follicular lymphoma, indicating its potential as a precise therapeutic target?","Among the genes DYNLT4, MDM2, SUMO1P1, ITGA4, and SRA1, which shows the most T-cell–specific expression in follicular lymphoma, indicating its potential as a precise therapeutic target? Identify all validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s T cell-activated genes and compute the average embedding for this overlapping subset. Then, calculate the cosine similarity between the average embedding and each individual embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['POLA1', 'ACTA2', 'DSP', 'GRID2IP', 'RNF114']",follicular lymphoma,t cell,POLA1,"Which gene among POLA1, ACTA2, DSP, GRID2IP, and RNF114 exhibits the highest T cell-specific expression, making it the most promising candidate for targeting follicular lymphoma?","Which gene among POLA1, ACTA2, DSP, GRID2IP, and RNF114 exhibits the highest T cell-specific expression, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the t cell–activated gene set in PINNACLE. Compute the average embedding of the overlapping targets and calculate the cosine similarity between this reference vector and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RCC2', 'NDUFB7', 'GOLGA1', 'MBD4', 'COMMD5']",follicular lymphoma,t cell,NDUFB7,"Which gene among RCC2, NDUFB7, GOLGA1, MBD4, and COMMD5 demonstrates the highest T cell-specific expression for targeted therapeutic approaches in follicular lymphoma?","Which gene among RCC2, NDUFB7, GOLGA1, MBD4, and COMMD5 demonstrates the highest T cell-specific expression for targeted therapeutic approaches in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which T cell-activated genes in PINNACLE overlap with these therapeutic targets. Using this overlapping set, compute the average embedding as a reference vector and calculate the cosine similarity between this reference and the individual target embeddings. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SGPL1', 'MAPK11', 'SLC9A3', 'DDB1', 'RAB40C']",follicular lymphoma,t cell,DDB1,"Among SGPL1, MAPK11, SLC9A3, DDB1, and RAB40C, which gene demonstrates the highest T cell–specific expression relevant to developing targeted therapies for follicular lymphoma?","Among SGPL1, MAPK11, SLC9A3, DDB1, and RAB40C, which gene demonstrates the highest T cell–specific expression relevant to developing targeted therapies for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the T cell-activated genes in PINNACLE. For the overlapping genes, compute their average embedding and then calculate the cosine similarity between this average embedding and the embedding of each individual target gene. If one gene exhibits a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['JAK3', 'C10orf67', 'DTX1', 'TMEM126B', 'FGF23']",follicular lymphoma,t cell,JAK3,"Which gene among JAK3, C10orf67, DTX1, TMEM126B, and FGF23 exhibits the highest T-cell–specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among JAK3, C10orf67, DTX1, TMEM126B, and FGF23 exhibits the highest T-cell–specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which T cell–activated genes in PINNACLE overlap with these validated targets to define a set of cell-type–specific targets. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene displays a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KDR', 'RAB11A', 'TUBB4B', 'TBC1D21', 'GNRHR']",follicular lymphoma,t cell,TUBB4B,"Among the genes KDR, RAB11A, TUBB4B, TBC1D21, and GNRHR, which one exhibits the highest T cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes KDR, RAB11A, TUBB4B, TBC1D21, and GNRHR, which one exhibits the highest T cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the T cell-activated genes in PINNACLE, and compute the average embedding of the overlapping set. Then, calculate the cosine similarity between this reference embedding and the embedding of each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MED22', 'DCTN4', 'ETFDH', 'BCL2L1', 'ARHGAP24']",follicular lymphoma,t cell,BCL2L1,"Among the genes MED22, DCTN4, ETFDH, BCL2L1, and ARHGAP24, which one exhibits the most T cell–specific expression and is therefore the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes MED22, DCTN4, ETFDH, BCL2L1, and ARHGAP24, which one exhibits the most T cell–specific expression and is therefore the most promising candidate for targeted therapy in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, compare these targets with the set of T cell–activated genes in PINNACLE to identify overlapping genes that serve as cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MXD4', 'RBX1', 'USB1', 'OR7A17', 'GRIP1']",follicular lymphoma,t cell,RBX1,"Which gene among MXD4, RBX1, USB1, OR7A17, and GRIP1 exhibits the highest T-cell specificity for targeting follicular lymphoma?","Which gene among MXD4, RBX1, USB1, OR7A17, and GRIP1 exhibits the highest T-cell specificity for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma that have cell-type–specific embeddings available in the PINNACLE dataset. Next, determine which of these targets overlap with the set of T cell-activated genes in PINNACLE, defining the overlapping genes as the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set, then compute the cosine similarity between the average embedding and each individual target's embedding. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RCN3', 'PLCL2', 'CD38', 'IVD', 'ATE1']",follicular lymphoma,t cell,CD38,"Which gene among RCN3, PLCL2, CD38, IVD, and ATE1 shows the most specific T cell expression, making it the best candidate for targeted intervention in follicular lymphoma?","Which gene among RCN3, PLCL2, CD38, IVD, and ATE1 shows the most specific T cell expression, making it the best candidate for targeted intervention in follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. From these, determine which targets overlap with the T cell–activated genes provided by PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding vector for this overlap and then calculate the cosine similarity between this reference vector and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['POLD3', 'CRTAC1', 'TADA2A', 'FOXR2', 'CLEC11A']",follicular lymphoma,t cell,POLD3,"Among the genes POLD3, CRTAC1, TADA2A, FOXR2, and CLEC11A, which one exhibits the highest T cell-specific expression, thereby representing the most promising target for follicular lymphoma therapy?","Among the genes POLD3, CRTAC1, TADA2A, FOXR2, and CLEC11A, which one exhibits the highest T cell-specific expression, thereby representing the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the T cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['KLF15', 'NDUFA4', 'TSPYL4', 'FIGN', 'MED25']",follicular lymphoma,t cell,NDUFA4,"Among the genes KLF15, NDUFA4, TSPYL4, FIGN, and MED25, which one demonstrates the highest T cell–specific expression, thereby representing the most promising target for follicular lymphoma therapy?","Among the genes KLF15, NDUFA4, TSPYL4, FIGN, and MED25, which one demonstrates the highest T cell–specific expression, thereby representing the most promising target for follicular lymphoma therapy? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the T cell-activated genes in PINNACLE to obtain a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CUL4A', 'OR8D2', 'PRRC2B', 'SOS1', 'BANF2']",follicular lymphoma,t cell,CUL4A,"Among the genes CUL4A, OR8D2, PRRC2B, SOS1, and BANF2, which shows the highest T cell–specific expression relevant to targeting follicular lymphoma?","Among the genes CUL4A, OR8D2, PRRC2B, SOS1, and BANF2, which shows the highest T cell–specific expression relevant to targeting follicular lymphoma? Using PINNACLE data, first extract the cell-type–specific embeddings for the validated therapeutic targets in follicular lymphoma. Then, identify which targets overlap with PINNACLE's T cell-activated gene set. For the overlapping targets, compute an average embedding as a reference, and calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDRG1', 'PIK3CG', 'TRIM23', 'SUCO', 'GCKR']",follicular lymphoma,t cell,PIK3CG,"Among the genes PDRG1, PIK3CG, TRIM23, SUCO, and GCKR, which one exhibits the highest T cell-specific expression relevant for targeted intervention in follicular lymphoma?","Among the genes PDRG1, PIK3CG, TRIM23, SUCO, and GCKR, which one exhibits the highest T cell-specific expression relevant for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma using PINNACLE's cell-type specific embeddings. Determine the overlap between these targets and PINNACLE’s t cell-activated genes. Next, compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SIRPG', 'TMEM144', 'NRIP3', 'USP49', 'PIK3R1']",follicular lymphoma,mature nk t cell,PIK3R1,"Among the genes SIRPG, TMEM144, NRIP3, USP49, and PIK3R1, which one shows the highest specificity in mature natural killer T (NKT) cells for targeted therapy against follicular lymphoma?","Among the genes SIRPG, TMEM144, NRIP3, USP49, and PIK3R1, which one shows the highest specificity in mature natural killer T (NKT) cells for targeted therapy against follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of mature NK T cell-activated genes in PINNACLE. Compute the average embedding for the overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LSG1', 'PMM2', 'CXCR4', 'SKA2', 'POLR3H']",follicular lymphoma,mature nk t cell,CXCR4,"Among the genes LSG1, PMM2, CXCR4, SKA2, and POLR3H, which one exhibits the highest cell-type specificity in mature NK T cells for targeted intervention in follicular lymphoma?","Among the genes LSG1, PMM2, CXCR4, SKA2, and POLR3H, which one exhibits the highest cell-type specificity in mature NK T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the mature NK T cell–activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between this average reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TP53RK', 'NDUFB7', 'FHL5', 'VPS13B', 'ERO1A']",follicular lymphoma,mature nk t cell,NDUFB7,"Which gene among TP53RK, NDUFB7, FHL5, VPS13B, and ERO1A exhibits the highest cell-type specificity in mature NK T cells, making it the most suitable target for follicular lymphoma therapy?","Which gene among TP53RK, NDUFB7, FHL5, VPS13B, and ERO1A exhibits the highest cell-type specificity in mature NK T cells, making it the most suitable target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of mature NK T cell-activated genes in PINNACLE to establish the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CRBN', 'CEP89', 'EPHB3', 'DAXX', 'KLKB1']",follicular lymphoma,mature nk t cell,CRBN,"Among the following genes—CRBN, CEP89, EPHB3, DAXX, and KLKB1—which one exhibits the highest cell-type specificity in mature NK T cells as a potential target for follicular lymphoma therapy?","Among the following genes—CRBN, CEP89, EPHB3, DAXX, and KLKB1—which one exhibits the highest cell-type specificity in mature NK T cells as a potential target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes among the mature NK T cell–activated genes in PINNACLE overlap with these therapeutic targets to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADAMTS1', 'SH2B2', 'GSTA2', 'MIA', 'NDUFB3']",follicular lymphoma,mature nk t cell,NDUFB3,"Which gene among ADAMTS1, SH2B2, GSTA2, MIA, and NDUFB3 exhibits the most cell-type–specific expression in mature NK T cells as a candidate target for follicular lymphoma?","Which gene among ADAMTS1, SH2B2, GSTA2, MIA, and NDUFB3 exhibits the most cell-type–specific expression in mature NK T cells as a candidate target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. From the mature NK T cell-activated gene set in PINNACLE, determine the overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBM41', 'LAG3', 'USF3', 'RBM8A', 'MCPH1']",follicular lymphoma,mature nk t cell,LAG3,"Which gene—RBM41, LAG3, USF3, RBM8A, or MCPH1—exhibits the highest cell-type specificity in mature NK T cells for targeted intervention in follicular lymphoma?","Which gene—RBM41, LAG3, USF3, RBM8A, or MCPH1—exhibits the highest cell-type specificity in mature NK T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap with mature NK T cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between the average and each individual gene's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CD86', 'MAP2K5', 'REEP6', 'TUBB', 'LRRC47']",follicular lymphoma,mature nk t cell,TUBB,"Which gene among CD86, MAP2K5, REEP6, TUBB, and LRRC47 exhibits the highest specificity for mature NK T cells, making it the most promising candidate for follicular lymphoma targeting?","Which gene among CD86, MAP2K5, REEP6, TUBB, and LRRC47 exhibits the highest specificity for mature NK T cells, making it the most promising candidate for follicular lymphoma targeting? Determine the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the mature NK T cell-activated genes in PINNACLE to define the cell-type–specific target set. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual gene embedding. If one gene demonstrates a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TP53INP2', 'NDUFB11', 'LRRC23', 'REN', 'CCDC8']",follicular lymphoma,mature nk t cell,NDUFB11,"Among the genes TP53INP2, NDUFB11, LRRC23, REN, and CCDC8, which exhibits the highest specificity for mature NK T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes TP53INP2, NDUFB11, LRRC23, REN, and CCDC8, which exhibits the highest specificity for mature NK T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, from the set of mature NK T cell–activated genes in PINNACLE, determine which ones overlap with these targets. For the overlapping genes, compute the average embedding and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['NDUFB4', 'ZBTB21', 'SLC11A2', 'SCAF8', 'LRP1B']",follicular lymphoma,mature nk t cell,NDUFB4,"Which gene among NDUFB4, ZBTB21, SLC11A2, SCAF8, and LRP1B exhibits the highest cell-type specificity in mature natural killer T cells for potential follicular lymphoma targeting?","Which gene among NDUFB4, ZBTB21, SLC11A2, SCAF8, and LRP1B exhibits the highest cell-type specificity in mature natural killer T cells for potential follicular lymphoma targeting? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell–activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of these overlapping targets as a reference, and then calculate the cosine similarity between the reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['C1QTNF2', 'H2AC1', 'UNC45A', 'YES1', 'TRIM52']",follicular lymphoma,mature nk t cell,YES1,"Which gene among C1QTNF2, H2AC1, UNC45A, YES1, and TRIM52 demonstrates the highest cell-type specificity in mature natural killer T cells, thereby representing the optimal candidate for targeting follicular lymphoma?","Which gene among C1QTNF2, H2AC1, UNC45A, YES1, and TRIM52 demonstrates the highest cell-type specificity in mature natural killer T cells, thereby representing the optimal candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which mature NK T cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['CACNB1', 'CEND1', 'SYPL2', 'DNMT1', 'RAB11B']",follicular lymphoma,mature nk t cell,DNMT1,"Among the genes CACNB1, CEND1, SYPL2, DNMT1, and RAB11B, which one demonstrates the highest cell-type specificity in mature NK T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes CACNB1, CEND1, SYPL2, DNMT1, and RAB11B, which one demonstrates the highest cell-type specificity in mature NK T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell–activated genes in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this reference vector and each individual target embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SH3BP4', 'PRMT8', 'NDUFA13', 'RTRAF', 'EME1']",follicular lymphoma,mature nk t cell,NDUFA13,"Among the genes SH3BP4, PRMT8, NDUFA13, RTRAF, and EME1, which one exhibits the highest cell-type specific expression in mature NKT cells for targeting follicular lymphoma?","Among the genes SH3BP4, PRMT8, NDUFA13, RTRAF, and EME1, which one exhibits the highest cell-type specific expression in mature NKT cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the set of mature NK T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding vector for this overlapping set, and then calculate the cosine similarity between this reference vector and the embedding of each individual target gene. If one gene demonstrates a markedly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC12A8', 'PIK3CD', 'NEK4', 'TFR2', 'ORMDL3']",follicular lymphoma,mature nk t cell,PIK3CD,"Among the genes SLC12A8, PIK3CD, NEK4, TFR2, and ORMDL3, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Among the genes SLC12A8, PIK3CD, NEK4, TFR2, and ORMDL3, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the mature NK T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity compared to the others, propose it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDZK1IP1', 'RAB22A', 'CEND1', 'IMPDH2', 'PRSS1']",follicular lymphoma,mature nk t cell,IMPDH2,"Which gene among PDZK1IP1, RAB22A, CEND1, IMPDH2, and PRSS1 exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Which gene among PDZK1IP1, RAB22A, CEND1, IMPDH2, and PRSS1 exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma using cell-type–specific embeddings from the PINNACLE database. Next, extract the genes activated in mature NK T cells from PINNACLE and identify the subset that overlaps with the therapeutic targets. Calculate the average embedding for these overlapping genes, then compute the cosine similarity between this average reference and each individual gene’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['FAM163B', 'GTF2A1L', 'HBEGF', 'CORO6', 'NDUFV2']",follicular lymphoma,mature nk t cell,NDUFV2,"Which gene among FAM163B, GTF2A1L, HBEGF, CORO6, and NDUFV2 exhibits the highest cell-type specificity in mature NK T cells targeting follicular lymphoma?","Which gene among FAM163B, GTF2A1L, HBEGF, CORO6, and NDUFV2 exhibits the highest cell-type specificity in mature NK T cells targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Then, determine which of these targets overlap with PINNACLE’s mature NK T cell activation genes to define the cell-type-specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'RTN4RL1', 'GMPR2', 'MIER3', 'TMTC3']",follicular lymphoma,mature nk t cell,NDUFS5,"Among the genes NDUFS5, RTN4RL1, GMPR2, MIER3, and TMTC3, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Among the genes NDUFS5, RTN4RL1, GMPR2, MIER3, and TMTC3, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE and retrieve their cell-type–specific embeddings. Then, determine the overlap between these targets and the mature NK T cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding vector as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FOXD4', 'MT-ND3', 'NR2E3', 'NCBP2AS2', 'RALGAPB']",follicular lymphoma,mature nk t cell,MT-ND3,"Among FOXD4, MT-ND3, NR2E3, NCBP2AS2, and RALGAPB, which gene exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Among FOXD4, MT-ND3, NR2E3, NCBP2AS2, and RALGAPB, which gene exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the mature NK T cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic candidates. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and each individual target gene. Finally, if one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SCML4', 'NDUFAF3', 'RPL36', 'PDE12', 'MRPL36']",follicular lymphoma,mature nk t cell,NDUFAF3,"Among the genes SCML4, NDUFAF3, RPL36, PDE12, and MRPL36, which one exhibits the highest cell-type specificity in mature NK T cells, making it the most suitable candidate for targeting follicular lymphoma?","Among the genes SCML4, NDUFAF3, RPL36, PDE12, and MRPL36, which one exhibits the highest cell-type specificity in mature NK T cells, making it the most suitable candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, from the set of mature NK T-cell activation genes in PINNACLE, select those that overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target gene embedding. If one gene shows markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MCL1', 'FOXP1', 'ZNF430', 'SERPINB1', 'PFDN6']",follicular lymphoma,mature nk t cell,MCL1,"Among the candidate genes MCL1, FOXP1, ZNF430, SERPINB1, and PFDN6, which one exhibits the highest cell-type specificity in mature NK T cells, making it the best target for follicular lymphoma?","Among the candidate genes MCL1, FOXP1, ZNF430, SERPINB1, and PFDN6, which one exhibits the highest cell-type specificity in mature NK T cells, making it the best target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which mature NK T cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding of the overlapping set as a reference. Finally, calculate the cosine similarity between this reference and each individual gene’s embedding, nominate the gene with the highest similarity as the top candidate, and provide a concise, evidence-based explanation of its biological relevance."
"['INKA1', 'RBX1', 'MAPK14', 'ZNF79', 'RBM33']",follicular lymphoma,mature nk t cell,RBX1,"Among the candidate genes INKA1, RBX1, MAPK14, ZNF79, and RBM33, which one exhibits the highest cell-type specificity in mature NK T cells, thereby representing the most promising target for follicular lymphoma intervention?","Among the candidate genes INKA1, RBX1, MAPK14, ZNF79, and RBM33, which one exhibits the highest cell-type specificity in mature NK T cells, thereby representing the most promising target for follicular lymphoma intervention? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, find the intersection with mature NK T cell-activated genes in PINNACLE to generate a refined set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL26L1', 'GAGE13', 'SLC5A1', 'TOP1', 'NEU4']",follicular lymphoma,myeloid cell,TOP1,"Which gene among RPL26L1, GAGE13, SLC5A1, TOP1, and NEU4 exhibits the highest level of myeloid cell-specific expression for potential targeting in follicular lymphoma?","Which gene among RPL26L1, GAGE13, SLC5A1, TOP1, and NEU4 exhibits the highest level of myeloid cell-specific expression for potential targeting in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the myeloid cell-activated genes in PINNACLE overlap with these targets to define the set of cell-type-specific targets. Calculate the average embedding for this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SMC3', 'SEC22A', 'NDUFA4', 'SP8', 'UBE2J2']",follicular lymphoma,myeloid cell,NDUFA4,"Which gene—SMC3, SEC22A, NDUFA4, SP8, or UBE2J2—displays the highest specificity for myeloid cells as a target for follicular lymphoma interventions?","Which gene—SMC3, SEC22A, NDUFA4, SP8, or UBE2J2—displays the highest specificity for myeloid cells as a target for follicular lymphoma interventions? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the subset of these targets that overlap with myeloid cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DCUN1D1', 'C5orf22', 'INTU', 'NDUFS5', 'IGSF8']",follicular lymphoma,myeloid cell,NDUFS5,"Among DCUN1D1, C5orf22, INTU, NDUFS5, and IGSF8, which gene exhibits the most specific expression in myeloid cells, making it the best candidate for targeting in follicular lymphoma?","Among DCUN1D1, C5orf22, INTU, NDUFS5, and IGSF8, which gene exhibits the most specific expression in myeloid cells, making it the best candidate for targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding of this overlapping set as a reference. Calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND2', 'FDX1', 'ZNRD2', 'RNF103-CHMP3', 'INPP5J']",follicular lymphoma,myeloid cell,MT-ND2,"Among the genes MT-ND2, FDX1, ZNRD2, RNF103-CHMP3, and INPP5J, which exhibits the highest myeloid cell-type specificity relevant to targeting follicular lymphoma?","Among the genes MT-ND2, FDX1, ZNRD2, RNF103-CHMP3, and INPP5J, which exhibits the highest myeloid cell-type specificity relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the myeloid cell–activated genes in PINNACLE. Next, calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, identify it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MYO1D', 'NDUFB6', 'DPH3', 'ARMC7', 'CACNA1G']",follicular lymphoma,myeloid cell,NDUFB6,"Which gene—MYO1D, NDUFB6, DPH3, ARMC7, or CACNA1G—exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Which gene—MYO1D, NDUFB6, DPH3, ARMC7, or CACNA1G—exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the myeloid cell-activated genes in PINNACLE, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between this reference embedding and the embedding of each target gene. Finally, if one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PIK3CB', 'VPS52', 'SEC11A', 'UBE2L6', 'COPS8']",follicular lymphoma,myeloid cell,PIK3CB,"Which gene among PIK3CB, VPS52, SEC11A, UBE2L6, and COPS8 exhibits the highest expression specificity in myeloid cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among PIK3CB, VPS52, SEC11A, UBE2L6, and COPS8 exhibits the highest expression specificity in myeloid cells, making it the optimal candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which myeloid cell-activated genes from PINNACLE overlap with these targets to define a set of follicular lymphoma-specific genes. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average vector and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GTF3C3', 'CD28', 'NXPH2', 'PBRM1', 'CRBN']",follicular lymphoma,myeloid cell,CRBN,"Which gene among GTF3C3, CD28, NXPH2, PBRM1, and CRBN exhibits the highest myeloid cell-specific expression relevant for targeting follicular lymphoma?","Which gene among GTF3C3, CD28, NXPH2, PBRM1, and CRBN exhibits the highest myeloid cell-specific expression relevant for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which myeloid cell–activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRR20A', 'ADGRL1', 'NDUFA12', 'ZBTB38', 'H2AC8']",follicular lymphoma,myeloid cell,NDUFA12,"Which gene among PRR20A, ADGRL1, NDUFA12, ZBTB38, and H2AC8 exhibits the highest myeloid cell-specific expression for targeted follicular lymphoma intervention?","Which gene among PRR20A, ADGRL1, NDUFA12, ZBTB38, and H2AC8 exhibits the highest myeloid cell-specific expression for targeted follicular lymphoma intervention? Identify the verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, from the genes activated in myeloid cells within PINNACLE, determine the overlapping ones with these therapeutic targets to define the cell-specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CALD1', 'MEPE', 'PGLYRP2', 'VPS33A', 'JAK1']",follicular lymphoma,myeloid cell,JAK1,"Among the genes CALD1, MEPE, PGLYRP2, VPS33A, and JAK1, which exhibits the highest cell-type specificity in myeloid cells for targeted intervention in follicular lymphoma?","Among the genes CALD1, MEPE, PGLYRP2, VPS33A, and JAK1, which exhibits the highest cell-type specificity in myeloid cells for targeted intervention in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with myeloid cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this set as a reference, then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND5', 'BAMBI', 'PCID2', 'B3GAT1', 'CT45A1']",follicular lymphoma,myeloid cell,MT-ND5,"Among the following genes—MT-ND5, BAMBI, PCID2, B3GAT1, and CT45A1—which one exhibits the highest specificity in myeloid cells for targeting follicular lymphoma?","Among the following genes—MT-ND5, BAMBI, PCID2, B3GAT1, and CT45A1—which one exhibits the highest specificity in myeloid cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Determine which myeloid cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['PPP2R2B', 'ZCCHC12', 'KCTD13', 'SPINK4', 'EZH2']",follicular lymphoma,myeloid cell,EZH2,"Which gene among PPP2R2B, ZCCHC12, KCTD13, SPINK4, and EZH2 exhibits the highest cell-type specificity in myeloid cells relevant for targeting follicular lymphoma?","Which gene among PPP2R2B, ZCCHC12, KCTD13, SPINK4, and EZH2 exhibits the highest cell-type specificity in myeloid cells relevant for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which myeloid cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in follicular lymphoma."
"['NDUFB7', 'GPKOW', 'MVP', 'MRPL14', 'DESI2']",follicular lymphoma,myeloid cell,NDUFB7,"Which gene among NDUFB7, GPKOW, MVP, MRPL14, and DESI2 exhibits the highest specificity in myeloid cells in the context of targeting follicular lymphoma?","Which gene among NDUFB7, GPKOW, MVP, MRPL14, and DESI2 exhibits the highest specificity in myeloid cells in the context of targeting follicular lymphoma? Identify and verify the therapeutic gene targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myeloid cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual gene’s embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['VMA21', 'CDK4', 'TNKS2', 'LDHA', 'C2orf50']",follicular lymphoma,myeloid cell,CDK4,"Among VMA21, CDK4, TNKS2, LDHA, and C2orf50, which gene exhibits the highest specificity for myeloid cells, making it the most promising candidate for targeting follicular lymphoma?","Among VMA21, CDK4, TNKS2, LDHA, and C2orf50, which gene exhibits the highest specificity for myeloid cells, making it the most promising candidate for targeting follicular lymphoma? Using PINNACLE data, identify the verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings. Next, determine which genes associated with myeloid cell activation in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and the embedding of each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['OMP', 'GSKIP', 'PRPF8', 'FAM169A', 'IMPDH2']",follicular lymphoma,myeloid cell,IMPDH2,"Among the genes OMP, GSKIP, PRPF8, FAM169A, and IMPDH2, which one demonstrates the highest cell-type specific expression in myeloid cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes OMP, GSKIP, PRPF8, FAM169A, and IMPDH2, which one demonstrates the highest cell-type specific expression in myeloid cells, making it the most promising candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which myeloid cell‐activated genes in PINNACLE overlap with these targets to define a cell-type–specific target set. Compute the average embedding of this set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EN1', 'XIST', 'NT5C', 'PPIA', 'MUC12']",follicular lymphoma,myeloid cell,PPIA,"Among the genes EN1, XIST, NT5C, PPIA, and MUC12, which one exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Among the genes EN1, XIST, NT5C, PPIA, and MUC12, which one exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Then, identify the overlap between these targets and the myeloid cell-activated genes in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ZNF705D', 'NDUFS2', 'PIK3C3', 'MORN2', 'MINDY2']",follicular lymphoma,myeloid cell,NDUFS2,"Among the genes ZNF705D, NDUFS2, PIK3C3, MORN2, and MINDY2, which one exhibits the highest myeloid cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes ZNF705D, NDUFS2, PIK3C3, MORN2, and MINDY2, which one exhibits the highest myeloid cell-specific expression, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which myeloid cell-activated genes overlap with these targets; these overlapping genes represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCDHGC3', 'RBMX2', 'SOX4', 'IFNAR1', 'ODF3L1']",follicular lymphoma,myeloid cell,IFNAR1,"Among the following genes—PCDHGC3, RBMX2, SOX4, IFNAR1, and ODF3L1—which one exhibits the highest myeloid cell-type specificity relevant for targeted therapy in follicular lymphoma?","Among the following genes—PCDHGC3, RBMX2, SOX4, IFNAR1, and ODF3L1—which one exhibits the highest myeloid cell-type specificity relevant for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell‐type–specific embeddings from PINNACLE. Next, determine which of the myeloid cell–activated genes in PINNACLE overlap with these targets, and compute the average embedding of this overlapping set as a reference. Calculate the cosine similarity between this reference and each individual target’s embedding, and if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate—supporting your choice with a concise, evidence‐based explanation of its biological relevance."
"['MTFR1L', 'MB21D2', 'GCSAM', 'PIK3CD', 'PRRX2']",follicular lymphoma,myeloid cell,PIK3CD,"Among MTFR1L, MB21D2, GCSAM, PIK3CD, and PRRX2, which gene displays the highest myeloid cell specificity in the context of follicular lymphoma targeting?","Among MTFR1L, MB21D2, GCSAM, PIK3CD, and PRRX2, which gene displays the highest myeloid cell specificity in the context of follicular lymphoma targeting? Retrieve cell-type–specific embeddings from PINNACLE for validated therapeutic targets of follicular lymphoma and identify which targets overlap with myeloid cell-activated genes. Calculate the average embedding for these overlapping genes, then compute the cosine similarity between this average and each individual target embedding. If one gene shows significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CAND1', 'LTBP1', 'ZCCHC3', 'BCL2A1', 'NUDC']",follicular lymphoma,myeloid cell,BCL2A1,"Which gene among CAND1, LTBP1, ZCCHC3, BCL2A1, and NUDC demonstrates the highest specificity in myeloid cells for targeting follicular lymphoma?","Which gene among CAND1, LTBP1, ZCCHC3, BCL2A1, and NUDC demonstrates the highest specificity in myeloid cells for targeting follicular lymphoma? Using PINNACLE data, identify the cell-type–specific embeddings for confirmed therapeutic targets of follicular lymphoma. Next, determine the overlap between these targets and the myeloid cell-activated genes in PINNACLE to define the refined target set. Calculate the average embedding of these genes as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['F3', 'SLC1A3', 'RGS5', 'CD22', 'FUT11']",follicular lymphoma,myeloid cell,CD22,"Among the genes F3, SLC1A3, RGS5, CD22, and FUT11, which exhibits the greatest specificity for myeloid cells and would serve as the optimal target for follicular lymphoma?","Among the genes F3, SLC1A3, RGS5, CD22, and FUT11, which exhibits the greatest specificity for myeloid cells and would serve as the optimal target for follicular lymphoma? Using a verified list of therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Identify the subset of these targets that overlap with myeloid cell-activated genes, then compute the average embedding for this overlapping set. Next, calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFC1', 'EIF3C', 'AKT1S1', 'RPL26L1', 'KMO']",follicular lymphoma,plasmacytoid dendritic cell,NDUFC1,"Which gene among NDUFC1, EIF3C, AKT1S1, RPL26L1, and KMO demonstrates the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among NDUFC1, EIF3C, AKT1S1, RPL26L1, and KMO demonstrates the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Using PINNACLE, identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes from PINNACLE. Calculate the average embedding for this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene has a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to follicular lymphoma."
"['CFHR5', 'LOXL1', 'DNMT1', 'SRFBP1', 'EMC9']",follicular lymphoma,plasmacytoid dendritic cell,DNMT1,"Among CFHR5, LOXL1, DNMT1, SRFBP1, and EMC9, which gene exhibits the highest specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among CFHR5, LOXL1, DNMT1, SRFBP1, and EMC9, which gene exhibits the highest specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy? Retrieve the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. For this overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['EGR4', 'NDUFA6', 'SERPINI1', 'CDK11A', 'ATG2A']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA6,"Among the genes EGR4, NDUFA6, SERPINI1, CDK11A, and ATG2A, which one exhibits the most restricted expression in plasmacytoid dendritic cells, making it the optimal target candidate for follicular lymphoma?","Among the genes EGR4, NDUFA6, SERPINI1, CDK11A, and ATG2A, which one exhibits the most restricted expression in plasmacytoid dendritic cells, making it the optimal target candidate for follicular lymphoma? Using the PINNACLE database, identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE to define a set of follicular lymphoma cell-type–specific targets. Calculate the average embedding of this set and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIOS', 'USB1', 'KRTAP10-10', 'THBS3', 'NDUFAF3']",follicular lymphoma,plasmacytoid dendritic cell,NDUFAF3,"Among the genes MIOS, USB1, KRTAP10-10, THBS3, and NDUFAF3, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes MIOS, USB1, KRTAP10-10, THBS3, and NDUFAF3, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and then calculate the cosine similarity between this average embedding and the individual target embeddings. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFNAR1', 'HNRNPLL', 'DCP1B', 'RPSA', 'PAFAH1B3']",follicular lymphoma,plasmacytoid dendritic cell,IFNAR1,"Among IFNAR1, HNRNPLL, DCP1B, RPSA, and PAFAH1B3, which gene exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among IFNAR1, HNRNPLL, DCP1B, RPSA, and PAFAH1B3, which gene exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that overlap with genes activated in plasmacytoid dendritic cells. Calculate the average embedding of this overlapping gene set to serve as a reference, then compute the cosine similarity between the reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance in follicular lymphoma."
"['RIBC2', 'NDUFA3', 'CPN1', 'CYB5A', 'CCDC85A']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA3,"Among the genes RIBC2, NDUFA3, CPN1, CYB5A, and CCDC85A, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes RIBC2, NDUFA3, CPN1, CYB5A, and CCDC85A, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Calculate the average embedding of these overlapping targets as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NXF1', 'EMC7', 'GOLGA8EP', 'TOP1', 'ACE']",follicular lymphoma,plasmacytoid dendritic cell,TOP1,"Among the genes NXF1, EMC7, GOLGA8EP, TOP1, and ACE, which one exhibits the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes NXF1, EMC7, GOLGA8EP, TOP1, and ACE, which one exhibits the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes listed in PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EVC2', 'MSH5', 'ATOX1', 'NDUFA7', 'CCNB3']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA7,"Among the genes EVC2, MSH5, ATOX1, NDUFA7, and CCNB3, which one exhibits the most specific expression in plasmacytoid dendritic cells, making it the prime candidate for targeting follicular lymphoma?","Among the genes EVC2, MSH5, ATOX1, NDUFA7, and CCNB3, which one exhibits the most specific expression in plasmacytoid dendritic cells, making it the prime candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes reported in PINNACLE to define the set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the principal candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HIPK1', 'C4orf46', 'PSMB5', 'PRM1', 'DLX3']",follicular lymphoma,plasmacytoid dendritic cell,PSMB5,"Which gene among HIPK1, C4orf46, PSMB5, PRM1, and DLX3 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for potential targeted intervention in follicular lymphoma?","Which gene among HIPK1, C4orf46, PSMB5, PRM1, and DLX3 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for potential targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these overlapping genes as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TLN2', 'MT-ND4L', 'ATP2B4', 'TMPRSS11D', 'RND3']",follicular lymphoma,plasmacytoid dendritic cell,MT-ND4L,"Among TLN2, MT-ND4L, ATP2B4, TMPRSS11D, and RND3, which gene exhibits the most exclusive expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among TLN2, MT-ND4L, ATP2B4, TMPRSS11D, and RND3, which gene exhibits the most exclusive expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the PINNACLE plasmacytoid dendritic cell–activated genes overlap with these targets. This overlapping set will represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between the average and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DUSP15', 'CCDC70', 'ABCE1', 'EIF2AK2', 'NDUFB10']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB10,"Among the genes DUSP15, CCDC70, ABCE1, EIF2AK2, and NDUFB10, which one exhibits the most cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes DUSP15, CCDC70, ABCE1, EIF2AK2, and NDUFB10, which one exhibits the most cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which genes activated in plasmacytoid dendritic cells within PINNACLE overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based explanation of its biological relevance."
"['TMEM102', 'FOSL1', 'HDAC2', 'LYPD6B', 'NOL8']",follicular lymphoma,plasmacytoid dendritic cell,HDAC2,"Among the candidate genes—TMEM102, FOSL1, HDAC2, LYPD6B, and NOL8—which one shows the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy?","Among the candidate genes—TMEM102, FOSL1, HDAC2, LYPD6B, and NOL8—which one shows the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE, defining the cell‐specific targets for follicular lymphoma. Calculate the average embedding for this set and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['APCS', 'NDUFB6', 'NR4A1', 'IFI16', 'GGT6']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB6,"Which gene among APCS, NDUFB6, NR4A1, IFI16, and GGT6 exhibits the most specific expression in plasmacytoid dendritic cells, thereby representing the best candidate for targeted intervention in follicular lymphoma?","Which gene among APCS, NDUFB6, NR4A1, IFI16, and GGT6 exhibits the most specific expression in plasmacytoid dendritic cells, thereby representing the best candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes from the plasmacytoid dendritic cell activation signature in PINNACLE overlap with these targets. Calculate the average embedding for this overlapping gene set, then compute the cosine similarity between the average embedding and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['ARHGEF11', 'KCNJ13', 'WDR25', 'NNAT', 'NDUFV2']",follicular lymphoma,plasmacytoid dendritic cell,NDUFV2,"Which gene among ARHGEF11, KCNJ13, WDR25, NNAT, and NDUFV2 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among ARHGEF11, KCNJ13, WDR25, NNAT, and NDUFV2 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in plasmacytoid dendritic cells, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['S100A9', 'NDUFB11', 'IL27', 'DAPK3', 'ZBTB42']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB11,"Among the genes S100A9, NDUFB11, IL27, DAPK3, and ZBTB42, which one exhibits the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes S100A9, NDUFB11, IL27, DAPK3, and ZBTB42, which one exhibits the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE resource. Then, determine which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the rest, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['MT-ND2', 'S100A11', 'GRHL1', 'CAMP', 'F2RL3']",follicular lymphoma,plasmacytoid dendritic cell,MT-ND2,"Which gene among MT-ND2, S100A11, GRHL1, CAMP, and F2RL3 exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted therapy against follicular lymphoma?","Which gene among MT-ND2, S100A11, GRHL1, CAMP, and F2RL3 exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted therapy against follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the plasmacytoid dendritic cell-activated genes in PINNACLE to define the cell-type–specific target set for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SPIB', 'IMPDH2', 'SIGLEC14', 'CSN3', 'FCSK']",follicular lymphoma,plasmacytoid dendritic cell,IMPDH2,"Which gene among SPIB, IMPDH2, SIGLEC14, CSN3, and FCSK exhibits the highest expression specificity in plasmacytoid dendritic cells and represents the most promising target for follicular lymphoma therapy?","Which gene among SPIB, IMPDH2, SIGLEC14, CSN3, and FCSK exhibits the highest expression specificity in plasmacytoid dendritic cells and represents the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the plasmacytoid dendritic cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB3D', 'TUBB6', 'PLA2G2E', 'ZNF165', 'NAA20']",follicular lymphoma,plasmacytoid dendritic cell,TUBB6,"Among the genes RAB3D, TUBB6, PLA2G2E, ZNF165, and NAA20, which exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes RAB3D, TUBB6, PLA2G2E, ZNF165, and NAA20, which exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the plasmacytoid dendritic cell‐activated genes in PINNACLE overlap with these targets, defining them as the cell‐type–specific targets for follicular lymphoma. Compute the average embedding from this overlapping set to serve as a reference vector, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CD38', 'VSTM1', 'KPNA6', 'PAPPA2', 'KRT25']",follicular lymphoma,plasmacytoid dendritic cell,CD38,"Among the genes CD38, VSTM1, KPNA6, PAPPA2, and KRT25, which exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes CD38, VSTM1, KPNA6, PAPPA2, and KRT25, which exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with plasmacytoid dendritic cell–activated genes in PINNACLE to establish the follicular lymphoma cell-type targets. Calculate the average embedding of this overlapping set as a reference value, then compute the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HDAC9', 'HLA-DRA', 'LRP11', 'RFX3', 'TLE3']",follicular lymphoma,plasmacytoid dendritic cell,HDAC9,"Among HDAC9, HLA-DRA, LRP11, RFX3, and TLE3, which gene exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Among HDAC9, HLA-DRA, LRP11, RFX3, and TLE3, which gene exhibits the highest specificity for plasmacytoid dendritic cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlap as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EIF5B', 'MT-ND4', 'MRPL28', 'LBHD1', 'ATP6V1B1']",follicular lymphoma,b cell,MT-ND4,"Which gene among EIF5B, MT-ND4, MRPL28, LBHD1, and ATP6V1B1 demonstrates the highest B cell-specific expression, making it the top candidate for targeted follicular lymphoma therapy?","Which gene among EIF5B, MT-ND4, MRPL28, LBHD1, and ATP6V1B1 demonstrates the highest B cell-specific expression, making it the top candidate for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the B cell–activated genes available in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. Finally, if a single gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RASL10A', 'COX6A2', 'SCN4B', 'TUBB2A', 'TNKS']",follicular lymphoma,b cell,TUBB2A,"Which gene among RASL10A, COX6A2, SCN4B, TUBB2A, and TNKS demonstrates the highest B cell specificity, making it the most appropriate candidate for targeted therapy in follicular lymphoma?","Which gene among RASL10A, COX6A2, SCN4B, TUBB2A, and TNKS demonstrates the highest B cell specificity, making it the most appropriate candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, intersect these targets with the B cell-activated genes in PINNACLE to obtain the set of cell-type–specific targets. Compute the average embedding of this set to serve as a reference, and then calculate the cosine similarity between the reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['NDUFAF4', 'ZNF626', 'NOP10', 'TMEM35A', 'GJB2']",follicular lymphoma,b cell,NDUFAF4,"Which gene among NDUFAF4, ZNF626, NOP10, TMEM35A, and GJB2 exhibits the highest specificity for B cells, thereby representing the best candidate for targeted therapy in follicular lymphoma?","Which gene among NDUFAF4, ZNF626, NOP10, TMEM35A, and GJB2 exhibits the highest specificity for B cells, thereby representing the best candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the b cell–activated genes in PINNACLE to define the specific gene set for follicular lymphoma. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SH3BP5', 'NFATC2IP', 'TNP2', 'CD19', 'CD48']",follicular lymphoma,b cell,CD19,"Among the genes SH3BP5, NFATC2IP, TNP2, CD19, and CD48, which one shows the highest B cell-specific expression, making it the best candidate for targeting follicular lymphoma?","Among the genes SH3BP5, NFATC2IP, TNP2, CD19, and CD48, which one shows the highest B cell-specific expression, making it the best candidate for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify which B cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for the disease. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene displays a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance in follicular lymphoma."
"['HCK', 'CBR1', 'TEKT5', 'SERP2', 'KCNE3']",follicular lymphoma,b cell,HCK,"Which gene among HCK, CBR1, TEKT5, SERP2, and KCNE3 demonstrates the highest specificity for B cells in the targeting of follicular lymphoma?","Which gene among HCK, CBR1, TEKT5, SERP2, and KCNE3 demonstrates the highest specificity for B cells in the targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine which B cell–activated genes in PINNACLE overlap with these therapeutic targets, forming the subset of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this subset and assess the cosine similarity of each individual target’s embedding to this average. If a single gene exhibits a significantly higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its bioactivity in follicular lymphoma."
"['CIITA', 'TGFBR2', 'MT-ND4L', 'BRD9', 'SLC25A42']",follicular lymphoma,b cell,MT-ND4L,"Among CIITA, TGFBR2, MT-ND4L, BRD9, and SLC25A42, which gene exhibits the highest cell-type specificity in B cells, making it the best candidate for targeting follicular lymphoma?","Among CIITA, TGFBR2, MT-ND4L, BRD9, and SLC25A42, which gene exhibits the highest cell-type specificity in B cells, making it the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, compare these with the B cell–activated gene embeddings from PINNACLE to identify the overlapping genes, which represent follicular lymphoma cell-type–specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['SIPA1L3', 'ZMYM2', 'DNAJA3', 'EIF4E2', 'JAK3']",follicular lymphoma,b cell,JAK3,"Which gene among SIPA1L3, ZMYM2, DNAJA3, EIF4E2, and JAK3 demonstrates the highest B cell-specific expression relevant for targeting follicular lymphoma?","Which gene among SIPA1L3, ZMYM2, DNAJA3, EIF4E2, and JAK3 demonstrates the highest B cell-specific expression relevant for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which B cell–activated genes in PINNACLE overlap with these targets to define the set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PLEKHA2', 'CD38', 'OGN', 'SYCE2', 'FBXO46']",follicular lymphoma,b cell,CD38,"Which gene among PLEKHA2, CD38, OGN, SYCE2, and FBXO46 exhibits the highest specificity for B cells, thereby representing the most promising target for follicular lymphoma therapy?","Which gene among PLEKHA2, CD38, OGN, SYCE2, and FBXO46 exhibits the highest specificity for B cells, thereby representing the most promising target for follicular lymphoma therapy? For follicular lymphoma, identify the validated therapeutic targets and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which B cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Then, calculate the average embedding for this overlapping set and compute the cosine similarity between this reference embedding and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NME5', 'CERKL', 'PHF19', 'CXCR4', 'VPS29']",follicular lymphoma,b cell,CXCR4,"Among NME5, CERKL, PHF19, CXCR4, and VPS29, which gene exhibits the highest B cell-specific expression and represents the most promising target for follicular lymphoma therapy?","Among NME5, CERKL, PHF19, CXCR4, and VPS29, which gene exhibits the highest B cell-specific expression and represents the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma from the PINNACLE dataset and extract their cell-type–specific embeddings. Determine which of these targets overlap with the set of B cell–activated genes, as this overlapping subset represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['H2AC4', 'NDUFC2', 'CYTOR', 'CCDC13', 'POGLUT1']",follicular lymphoma,b cell,NDUFC2,"Among the candidate genes H2AC4, NDUFC2, CYTOR, CCDC13, and POGLUT1, which one shows the highest B cell-specific expression relevant to targeting follicular lymphoma?","Among the candidate genes H2AC4, NDUFC2, CYTOR, CCDC13, and POGLUT1, which one shows the highest B cell-specific expression relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which B cell–activated genes in PINNACLE overlap with these targets, and use this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these targets as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BBOX1', 'ZNF69', 'MOB3C', 'HSD17B2', 'CDK7']",follicular lymphoma,b cell,CDK7,"Among the genes BBOX1, ZNF69, MOB3C, HSD17B2, and CDK7, which shows the highest specificity for B cells in the context of follicular lymphoma targeting?","Among the genes BBOX1, ZNF69, MOB3C, HSD17B2, and CDK7, which shows the highest specificity for B cells in the context of follicular lymphoma targeting? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, identify which of these targets overlap with the B cell–activated genes in the database to define the cell-type-specific targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS2', 'GOT2', 'RFX7', 'ACVR1B', 'ICAM4']",follicular lymphoma,b cell,NDUFS2,"Which gene among NDUFS2, GOT2, RFX7, ACVR1B, and ICAM4 demonstrates the highest B cell-specific expression, making it a promising target for follicular lymphoma therapy?","Which gene among NDUFS2, GOT2, RFX7, ACVR1B, and ICAM4 demonstrates the highest B cell-specific expression, making it a promising target for follicular lymphoma therapy? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which B cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a considerably higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['AMN', 'SWI5', 'DEFB127', 'DENND4A', 'MS4A1']",follicular lymphoma,b cell,MS4A1,"Which gene among AMN, SWI5, DEFB127, DENND4A, and MS4A1 exhibits the most B cell-specific expression, making it the optimal candidate for targeting follicular lymphoma?","Which gene among AMN, SWI5, DEFB127, DENND4A, and MS4A1 exhibits the most B cell-specific expression, making it the optimal candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine which B cell-activated genes in PINNACLE overlap with these therapeutic targets, and compute an average embedding from these overlapping genes. Then calculate the cosine similarity between this average embedding and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANKS4B', 'KTI12', 'SPRR1B', 'HSP90AB1', 'ZNF141']",follicular lymphoma,b cell,HSP90AB1,"Among the genes ANKS4B, KTI12, SPRR1B, HSP90AB1, and ZNF141, which one exhibits the highest B cell–specific expression, making it the most promising target gene for follicular lymphoma therapy?","Among the genes ANKS4B, KTI12, SPRR1B, HSP90AB1, and ZNF141, which one exhibits the highest B cell–specific expression, making it the most promising target gene for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and acquire their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of B cell–activated genes from PINNACLE to define the cell-type-specific target group. Compute the average embedding for this overlapping group, then calculate the cosine similarity between the average embedding and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GGT1', 'C16orf87', 'NOTCH2NLA', 'C10orf90', 'NDUFB3']",follicular lymphoma,b cell,NDUFB3,"Which gene among GGT1, C16orf87, NOTCH2NLA, C10orf90, and NDUFB3 exhibits the highest B cell-specific expression, making it the most promising candidate for targeted follicular lymphoma therapy?","Which gene among GGT1, C16orf87, NOTCH2NLA, C10orf90, and NDUFB3 exhibits the highest B cell-specific expression, making it the most promising candidate for targeted follicular lymphoma therapy? Using the PINNACLE dataset, identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and B cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target's embedding. If one gene displays a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FYN', 'DDT', 'SCGB3A1', 'ADARB2', 'ALYREF']",follicular lymphoma,b cell,FYN,"Among the genes FYN, DDT, SCGB3A1, ADARB2, and ALYREF, which one demonstrates the highest B cell specificity for targeted intervention in follicular lymphoma?","Among the genes FYN, DDT, SCGB3A1, ADARB2, and ALYREF, which one demonstrates the highest B cell specificity for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the B cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference profile, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACO1', 'CDK9', 'AP1G2', 'PYY', 'TENT5C']",follicular lymphoma,b cell,CDK9,"Which gene among ACO1, CDK9, AP1G2, PYY, and TENT5C demonstrates the highest specificity for B cells in the context of targeting follicular lymphoma?","Which gene among ACO1, CDK9, AP1G2, PYY, and TENT5C demonstrates the highest specificity for B cells in the context of targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, identify the intersection between these targets and the B cell-activated genes in PINNACLE. Compute the average embedding of this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['YWHAH', 'NDUFS7', 'RTP4', 'SCX', 'SBF1']",follicular lymphoma,b cell,NDUFS7,"Among the genes YWHAH, NDUFS7, RTP4, SCX, and SBF1, which one exhibits the most specific expression in B-cells, thereby serving as the optimal target for follicular lymphoma therapies?","Among the genes YWHAH, NDUFS7, RTP4, SCX, and SBF1, which one exhibits the most specific expression in B-cells, thereby serving as the optimal target for follicular lymphoma therapies? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which b cell–activated genes from PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If a single gene exhibits a substantially higher similarity score compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MFSD14B', 'ZSWIM9', 'PPIA', 'KIF11', 'AMBP']",follicular lymphoma,b cell,PPIA,"Which gene—MFSD14B, ZSWIM9, PPIA, KIF11, or AMBP—demonstrates the highest specificity in B cells, thus emerging as the most promising candidate for targeted follicular lymphoma therapy?","Which gene—MFSD14B, ZSWIM9, PPIA, KIF11, or AMBP—demonstrates the highest specificity in B cells, thus emerging as the most promising candidate for targeted follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of B cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this intersected set and calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EIF2AK2', 'DFFA', 'TOP2A', 'TSPYL2', 'RALBP1']",follicular lymphoma,b cell,TOP2A,"Which gene—EIF2AK2, DFFA, TOP2A, TSPYL2, or RALBP1—displays the highest B cell-specific expression relevant for targeting follicular lymphoma?","Which gene—EIF2AK2, DFFA, TOP2A, TSPYL2, or RALBP1—displays the highest B cell-specific expression relevant for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, from the set of B cell-activated genes in PINNACLE, determine the overlapping genes with these targets. Calculate the average embedding of this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
